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Abstract
This thesis aimed to determine the psychometric properties and applications of sensory threshold
tools and outcome measures in patients with Carpal Tunnel Syndrome (CTS). The first chapter
is a psychometric study that defines clinically important difference (CID), construct validity and
responsiveness of touch and vibration threshold tools and in the Symptoms Severity Scale (SSS).
The study found the CID for the Pressure Specified Sensory Device (PSSD) and for the SSS was
0.15g/mm2 and 0.50 respectively.

The study also found that the Vibrometer was more

representative of hand function and responsive compared PSSD. The second objective of this
thesis was to determine the feasibility of recruiting patients with CTS to test the effects of cell
phone texting on sensory and functional outcome measures. The recruitment rate was 73% and
touch threshold was most influenced by texting for patients. Further research is required on the
process of clinical decision making based on sensory tool evaluations.

Keywords
Carpal Tunnel Syndrome, sensation, Clinical Important Difference (CID), construct validity,
responsiveness, feasibility, cell phone.
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Chapter 1

1

Background

Carpal Tunnel Syndrome (CTS) is one of the most common neuropathies to the upper
extremity. In general, the presenting symptoms associated to CTS are the result of the
compression of the median nerve beneath the transverse retinaculum.

1

Common signs

and symptoms in diagnosed CTS are: numbness, tingling, and pain in the hand, and
nocturnal symptoms.

2

The cause of CTS is controversial, as it can be caused by a

multitude of physiological changes to the nerve, surrounding structures within the carpal
tunnel structure, or vascular changes. Some reasons for the cause of CTS include:
edema causing increase pressure within the carpal tunnel,
of blood resulting in ischemia by surrounding tissue.

3

1

fibrosis,

1

or the entrapment

Chronic compression of the nerve

has been thought to result in decreased blood flow to large fibers and result in
demyelination.

4

One of the common symptoms to CTS are sensory changes, and in the

ability for patients to perceive specific stimuli, particularly touch and vibration threshold.
Vibration threshold changes occur early in neuropathy, while pressure thresholds tend to
change in later stages of CTS. 5 Sensory recovery is an important part of the rehabilitation
process for patients with CTS. During the evaluative process of patients with CTS, it is
important that sensory tools provide useful information to inform clinicians on the status
of the patients’ sensory recovery and to make decisions 6on whether to proceed with
different treatment or to end treatment. Tools should be validated for construct validity,

6

be responsive to treatment, 6 and have a defined clinically important difference.
Furthermore, beyond clinical use, the application of sensory tools could be used in testing
novel day to day activities which patients may come across. It is possible that specific
activities may alter sensation and aggravate symptoms patients currently experience.
With these concepts in mind, this thesis is intended to explore the psychometric
properties and specific applications of sensory tools and outcome measures. We will
briefly summarize the epidemiology, clinical background on sensory changes, properties

2
of the Pressure Specified Sensory Device (PSSD) and Vibrometer, summary of
limitations in current literature, and an overview of the objectives for this thesis.

1.1

Epidemiology

Within the province of Ontario in Canada, CTS occurred at rate of 29 out of 100,000
workers in 1997. 7 More than half of the persons affected are women (54%) and generally
occur between 35- 54 years of age. 7, 8 In 1997, the injury was highest among the textile,
fur and leathers, machine operation, and transportation. 7 In the United States of America,
occupational surveys from data in 2010 reported that the lifetime prevalence of clinician
diagnosed CTS was 6.7% of the population. 9
The risk factors or potential causes of CTS within workplaces have been studied
extensively. Potential reasons for the cause of CTS are: nature of the job demands,
gender differences, elevated body mass index,
mechanical neck problem),
diabetes).

11, 12

10

10

medical history (previous fracture or

individual characteristics (caffeine consumption and

For professions requiring highly repetitive movement involving awkward

postures of the upper extremity, mechanical pressure on finger tips, and twisting of the
wrist have been documented to have a higher risk of workers developing CTS than jobs
not requiring such tasks13. Other reasons that may cause CTS are pregnancy
recent injury to the upper extremity.

20

14-19

and

Recent injury to the upper extremity may cause

carpal tunnel syndrome because of potential impingement of the median nerve in cases
with distal radius fractures.

20

There is controversy about the extent to which CTS is

work-related or a result of genetic factors, and how these are reflected in health
conditions with co-morbidities.

3

1.2

Clinical Presentation of CTS

When nerve injury occurs, there is first intermittent paraesthesia that is experienced. 21
As neuropathy progresses, patients experience constant paraesthesia, and weakness in the
hand. 21 In late stages, there is numbness and potential paralysis in the hand. 21 Sensation
is altered and an increase in touch and vibration threshold occurs during early stages of
nerve injury. 4 There are five classes of nerve injury, where the severity is rated from 1 to
5. Carpal tunnel syndrome is a compression neuropathy that crosses categories 1 to 3
because categories 4 and 5 involve transection of the nerve (Table 1). 4, 5, 22 Each category
of CTS presents itself with different presentation of alterations to sensation from
physiological changes to the median nerve and associated structures (motor and sensory)
to the median nerve.
Table 1.1: Categories of Nerve Injury Classification
Neuropraxia

Axonotmesis

Sunderland

Category 1 (early

Category 2 – axon loss.

Category 3 (late stage

Categories of

stage of CTS):

Intact endoneurium.

CTS) – loss of

Nerve Injury

Conduction block,

Wallerian degeneration

continuity of axons and

Classification

Axon remained

of distal nerver and

endoneurium.

and

normal. Initial

myelin sheath.

Perineurium intact.

Presentation

sensation of

Wallerian degeneration

parathesia.

At distal end.
Endoneural scarring.

Focal
demyelination

Chance of recovery
dependent on content in
fascicles.

4

Mild
Symptomology Mild symptoms of
4, 22, 23

Moderate

Severe

Persistent symptoms

Prolonged neuropraxia

Decreased tactile

Marked by decreased

sensation

2PD

Loss of dexterity

Decreased tactile

tingling, pain, and
numbness
Mainly nocturnal
symptoms

gnosis
Day symptoms –

Weak grip and pinch
Impaired dexterity and

wrist in flexed

Symptoms increase at

position at 1min

night

No abnormal

Burning pain, swelling

findings

or tightness in hand

function
Weakness of 2

+/- Tinel and

Varied degree of thenar

Phalen’s

weakness/atrophy

lumbricals and thenar
muscles.
Atrophic skin changes
+/- Tinel’s and

Skin changes
Decreased protective
sensation
Greater 2PD values
Definite +ve Tinel’s
and Phalen’s
Decreased nerve
conduction on EMG
PD = point discrimination. EMG = Electromyography

Phalen’s
Severely decreased
nerve conduction on
EMG

5
Categories 4 and 5 of Sunderland Categories of Nerve Injury Classification do not
represent CTS because they involve complete transaction of the nerve. Nerve transection
is not a characteristic of CTS.

1.3

Treatment

The initial treatment process of non severe cases of CTS usually involves non surgical
treatment, often involving orthotic intervention (splinting).

24

If orthotic intervention

fails, surgery is the next level of treatment. 25 The decision to proceed to surgery is based
on patient’s concerns, and/or based on the clinician’s decision from a number of clinical
outcome measures. The clinician’s decision to send a patient on towards surgery or to
end treatment is based on whether the changes in outcome measures from follow up
appointment presented a clinically important difference. Ozyurekoglu et al

26

calculated

the minimal clinically important difference (MCID) for the Symptom Severity Scale
(SSS) in a group of patients with CTS after conservative treatment with steroid injection.
They found that the MCID was 1.04 on the SSS.

26

However, we are unaware from

previous literature on the clinically important difference for orthotic intervention.
Likewise, clinicians use a battery of sensory tests, such as touch threshold and vibration
threshold, to evaluate sensory threshold. We are uncertain of previous literature which
has documented the clinically important difference of the SSS and sensory threshold tools
after orthotic intervention. A study is needed to address this gap in literature.

1.4

Clinical Outcome Measures and Properties

Pressure specified sensory device (PSSD). The Pressure Specified Sensory
Device (PSSD) is a sensory threshold tool used commonly within research
settings. The PSSD can measure static one point (1PS), static two point (2PS),
moving one point discrimination (1PM), and moving two point discrimination
(2PM). The purpose of these tests are to measure cutaneous pressure threshold on
the surface of skin to detect pressure (1 point testing) and to discriminate one
prong from two prongs (2 point testing), targeting sensory receptors for measuring

6
both static and dynamic stimuli. 27 The PSSD has demonstrated construct validity
in relation to the nerve conduction studies,
2PD,

30

28, 29

with object identification with

and valid to be used for groups with neuropathy caused by diabetes.

The PSSD has shown to be a reliable tool,

27

31

and shows expected physiological

relationships between pressure threshold and the distance between stimuli.

32

Although there are many sensory tools, the PSSD cannot be compared to other
measurement tools for sensation, such as Semmes Weinstein monofilament
(SWMF) because poor correlations have been shown between the two tools (r =
0.21 - .29).

33

Thus, previous psychometric properties determined for the SWMF

should not be used as evidence to support the PSSD, although they both measure
the construct of touch threshold, 1 point and 2 point testing for both static and
dynamic. The PSSD has been extensively studied using 2 point discrimination,

30

but 1 point static testing has not been validated for construct validity in relation to
symptom severity, self reported hand function, and dexterity for patients with
CTS. The PSSD values have been shown to significantly change after carpal
tunnel release,

34

but a study on responsiveness of the PSSD has not been

examined. Quantifying the responsiveness would allow the responsiveness of the
PSSD to be compared to other sensory measures.

An examination of the

psychometric properties would be required to justify the utility of touch threshold
testing with 1 point of the PSSD in patients with CTS.
The Vibrometer. The Vibrometer measures vibration threshold or the minimum
amount of stimulus that is required to elicit a response (with the vibration
amplitude usually measured in micrometers (um). The Vibrometer is commonly
used for diagnostic purposes to detect for impairments to the peripheral nerve 35, 36
because the fibers responsible for detecting vibration threshold are affected early
during neuropathy. 4 The Vibrometer has been found to have low construct
validity with nerve conduction studies, 35, 37-40 but mixed findings on whether it is
more sensitive to detect neuropathy compared to standard nerve conduction
testing. 37 The Vibrometer has demonstrated moderate correlation with dexterity
testing (r = -0.62). 30 The tool has also been found to be reliable. 41, 42 However,

7
the construct validity of the tool has not been assessed in relation to self reported
measures of function and symptom severity. There is a disproportional amount of
research focus on relating performance based tools (i.e. electromyography) to
represent function, rather than determining the association of vibration threshold
to the symptoms (for example, pain or numbness) that patients experience. An
examination of self reported symptoms in relation to vibration threshold would
allow clinicians to make more informed decisions by understanding how vibration
threshold is associated to patients’ hand function. In addition, there is no clear cut
point to indicate a clinically important difference for the Vibrometer for
evaluating patients with CTS who undergo orthotic intervention to determine
whether they should continue to proceed with surgery or to end treatment.
Symptom severity scale (SSS). The Symptom Severity Scale (SSS) is a
questionnaire with 11 questions 43, 44 specifically designed to assess the symptom
severity experienced by patients with CTS. 43 The tool has demonstrated construct
validity, 43 and reliability. 43, 45 The SSS has also been shown to be responsive
after treatment for surgery, 44, 46-48 and after steroid injection. 26 The minimal
clinically important difference has been demonstrated for surgery, 48 and after
steroid injection. 26 However, the cut point for clinically important difference is
for the SSS after orthotic intervention has not been established. The clinically
important difference may help clinicians discriminate whether patients should
proceed to surgery or not after orthotic intervention. When testing for clinical
properties of sensory tools, in theory, the SSS should demonstrate a correlation
with overall hand function and dexterity. However, previous research has not
shown the association between the SSS to other measures of hand function. It is
not clear how symptoms are correlated to hand function. A psychometric study
should be performed to establish the cut point for the clinically important
difference and the construct validity of the SSS in relation to self reported
measures of hand function.

8

1.5

Changes to Blood Flow

In a patient affected with CTS, there is a breakdown of the blood nerve barrier of the
median nerve from elevated pressure, resulting in inflammation within the tissue. 49
Previous research has found that patients have impaired control of blood flow. 50-55
Previous in-lab and clinical testing has found that the sympathetic response is slower and
recovery is delayed before and after exercise in patients with CTS. 50-55 Patients with CTS
have also been shown to have slower blood flow velocities compared to people without
CTS. 50, 52, 53 One study indicated that blood flow was faster in patients with CTS
compared to healthy participants. 52 These previous studies 50, 52, 53 have utilized Doppler
system and thermography to measure vascular performance in patients with CTS.
However, one of the limitations of these tools is that they cannot measure red blood cell
concentration specifically at one instantaneous point time, and can only measure blood
flow. Focusing on an instantaneous red blood cell concentration would be advantageous
to describe the influence of CTS on blood circulation in areas where sensation is altered.
In addition, we can see how specific activities with the hand would influence blood flow.
This information would be useful for understanding how blood circulation is affected by
CTS.

1.6

Applications of Sensory Tools in Hand Activity: Cell Phone Use

Cell phone texting is an increasingly popular method of communication,56 and research
describing the physiological changes from texting is fairly novel among different
populations. Most research on describing physiological changes from cell phone texting
57-59

has primarily focused on university student populations with and without

musculoskeletal symptoms. Gustafsson et al 57 found that subjects with musculoskeletal
symptoms had lower muscle activity in the thumbs but higher activity in the trapezius
compared to those participants without symptoms. 57 In a preliminary study, Lin and
Peper 58 found that texting increases respiratory rate, heart rate, and self reported stress
levels. 58 Research studies have also suggested that cell phone texting may result in pain
experienced on the upper extremity. 59 To our knowledge, no research has examined the

9
effect of cell phone texting on a patient population with clinically diagnosed CTS.
Postures, motions, and forces obtained during cell phone texting by patients with CTS
may result in an increase in sensory thresholds, altered blood flow, and aggravated
symptoms. Understanding the sensory, vascular, and symptomatic changes that may
occur with texting might allow clinicians or ergonomists to understand the impact of
texting on clinical outcome measures in a patient population with CTS. The first stage of
research should be to determine the immediate impact of texting in patients and in age
matched controls to determine if there are immediate changes in physiological function in
responses to clinical tools. The findings from this pilot study would inform the feasibility
of completing a larger future study on the long-term effects of texting. A feasibility study
should be performed to determine the influence of texting on clinical outcome measures
in patients with CTS on this novel topic.

1.7

Summary of Limitations in Current Knowledge

Sensory evaluation is an important part of the treatment process to evaluate the severity
of CTS that patients have. It is important that tools can discriminate patients with CTS
who have undergone treatment and to determine the next step in the treatment process,
specifically whether patients with CTS going through orthotic intervention should
continue towards surgery or not. It would be equally important to know the
responsiveness of sensory tools and construct validity of sensory tools to determine
which sensory tools are more representative of hand function. However, we could not
locate these psychometric properties in previous literature on the PSSD and the
Vibrometer. In addition, the application of sensory tools to measure sensory and
functional changes in patients with CTS under conditions after newly emerging hand
activity, such as texting on a cell phone. These findings would provide insight into how
patient populations are affected by texting activity and their performance are impacted by
CTS.
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1.8

Purpose of this Thesis

The central question of this thesis was to determine the physiological response to
(potentially risky) exposures and intervention in patients with CTS and its potential
impact on sensory improvement.
This thesis attempted to identify the following objectives in patients with CTS:


The psychometric properties of two sensory threshold devices (the Pressure
Specified Sensory Device (PSSD) and Vibrometer), and the Symptom Severity
Scale (SSS), in terms of the clinically important difference, construct validity to
functional outcome measures, and responsiveness after orthotic intervention



The potential differences in sensory measures and outcome measures between
patients and healthy individuals after texting on a cell phone through a pilot study

1.9

Thesis Overview

This thesis is composed of 2 manuscripts. The first manuscript is located in Chapter 2
and the second manuscript is located in Chapter 3.
The aim of the manuscript in Chapter 2 was to determine a number of the psychometric
properties of the Pressure Specified Sensory Device (PSSD), the Vibrometer and the
Symptom Severity Scale (SSS). Specifically, the primary objective of this study was to
determine the CID of the sensory tools and in the SSS to discriminate patients who were
successfully treated with orthotic intervention and patients who needed to proceed further
with surgery. The secondary objective of this study was to determine the construct
validity and responsiveness of sensory threshold tools and in the SSS. This study was
able to identify differences in properties between the PSSD and the Vibrometer, suggest
rational for these properties, and which tool would be more useful in discriminating
patients with CTS after orthotic intervention and representative of overall hand function.
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Chapter 3 was dedicated to determining the feasibility of recruiting patients with CTS,
and to describe the effects of cell phone texting on their touch threshold, superficial blood
flow, and self reported symptom ratings. The objective of the study was to determine
differences between a group of patients with CTS to an age-and-gender matched control
group. We determined that a full study to determine the effects of cell phone texting was
feasible to perform over the recruitment period and a full study could be completed in the
future. We were able to identify factors which reduced the number of eligible patients in
the study. We also found that patients experienced more symptoms throughout the study
compared to age and gender matched controls and symptoms worsened from texting.
Patients experienced a significant increased in touch threshold and fatigue compared to
baseline levels after texting. Since studies the physiological effects of cell phone texting
are limited, this study serves as an early effort to describe potential adverse effects of cell
phone texting in a patient population with CTS and in healthy age and gender matched
controls.
In summary, this thesis is intended to bridge specific gaps in literature behind the
measurement properties of sensory tools for evaluating patients with CTS in clinical and
non clinical environments.

12

1.10

References

1. Werner RA, Andary M. Carpal tunnel syndrome: pathophysiology and clinical
neurophysiology. Clinical Neurophysiology. 2002;113:1373-1381.
2. Rempel D, Evanoff B, Amadio PC, et al. Consensus criteria for the classification of
carpal tunnel syndrome in epidemiologic studies. Am J Public Health. 1998;88:1447.
3. Sunderland S. The nerve lesion in the carpal tunnel syndrome. J Neurol Neurosurg
Psychiatry. 1976;39:615-626.
4. MacDermid JC, Wessel J. Clinical diagnosis of carpal tunnel syndrome: a systematic
review. Journal of Hand Therapy. 2004;17:309-319.
5. Maggi SP, Lowe 3rd J, Mackinnon SE. Pathophysiology of nerve injury. Clin Plast
Surg. 2003;30:109.
6. Finch E, Dina. Brooks, Stratford PW. Physical rehabilitation outcome measures. .
2002.
7. Zakaria D. Rates of carpal tunnel syndrome, epicondylitis, and rotator cuff claims in
Ontario workers during 1997. Chronic Dis Can. 2004;25:32-39.
8. Ibrahim T, Majid I, Clarke M, Kershaw CJ. Outcome of carpal tunnel decompression:
The influence of age, gender, and occupation. Int Orthop. 2009;33:1305-1309.

13
9. Luckhaupt SE, Dahlhamer JM, Ward BW, Sweeney MH, Sestito JP, Calvert GM.
Prevalence and work-relatedness of carpal tunnel syndrome in the working population,
United States, 2010 national health interview survey. Am J Ind Med. 2012.
10. Ferry S, Hannaford P, Warskyj M, Lewis M, Croft P. Carpal tunnel syndrome: a
nested case-control study of risk factors in women. Am J Epidemiol. 2000;151:566-574.
11. Atcheson SG, Ward JR, Lowe W. Concurrent medical disease in work-related carpal
tunnel syndrome. Arch Intern Med. 1998;158:1506.
12. Nathan PA, Keniston RC, Lockwood RS, Meadows KD. Tobacco, caffeine, alcohol,
and carpal tunnel syndrome in American industry: a cross-sectional study of 1464
workers. Journal of occupational and environmental medicine. 1996;38:290.
13. Burt S, Crombie K, Jin Y, Wurzelbacher S, Ramsey J, Deddens J. Workplace and
individual risk factors for carpal tunnel syndrome. Occup Environ Med. 2011;68:928933.
14. Jurjevic A, Bralic M, Antoncic I, Dunatov S, Legac M. Early onset of carpal tunnel
syndrome during pregnancy: case report. Acta Clin Croat. 2010;49:77-80.
15. Padua L, Di Pasquale A, Pazzaglia C, Liotta GA, Librante A, Mondelli M. Systematic
review of pregnancy-related carpal tunnel syndrome. Muscle Nerve. 2010;42:697-702.
16. Mondelli M, Rossi S, Monti E, et al. Long term follow-up of carpal tunnel syndrome
during pregnancy: a cohort study and review of the literature. Electromyogr Clin
Neurophysiol. 2007;47:259-271.

14
17. Tejerizo LC, Moro J, Sanchez MM, et al. Carpal tunnel syndrome in pregnancy.
Progresos en Obstetricia y Ginecologia. 1999;42:659-668.
18. Ekman-Ordeberg G, Salgeback S, Ordeberg G. Carpal tunnel syndrome in pregnancy.
A prospective study. Acta Obstet Gynecol Scand. 1987;66:233-235.
19. Seror P. Carpal tunnel syndrome during pregnancy. J Gynecol Obstet Biol Reprod.
1997;26:148-153.
20. Dyer G, Lozano-Calderon S, Gannon C, Baratz M, Ring D. Predictors of Acute
Carpal Tunnel Syndrome Associated With Fracture of the Distal Radius. J Hand Surg.
2008;33:1309-1313.
21. Mackinnon SE. Pathophysiology of nerve compression. Hand Clin. 2002;18:231-241.
22. Berger RA, Weiss APC. Basic pathology of the hand, wrist, and forearm: Nerve. In:
Mackinnon SE, Dvali L, eds. Hand Surgery. Vol 1. Lippincott Williams & Wilkins;
2004.
23. Dellon AL. Evaluation of Sensibility and Re-Education of Sensation in the Hand.
Williams & Wilkins Baltimore; 1981.
24. Kaplan SJ, Glickel SZ, Eaton RG. Predictive factors in the non-surgical treatment of
carpal tunnel syndrome. J Hand Surg. 1990;15 B:106-108.
25. Shi Q, MacDermid JC. Is surgical intervention more effective than non-surgical
treatment for carpal tunnel syndrome? a systematic review. Journal of orthopaedic
surgery and research. 2011;6:1-9.

15
26. Ozyurekoglu T, McCabe SJ, Goldsmith LJ, LaJoie AS. The minimal clinically
important difference of the Carpal Tunnel Syndrome Symptom Severity Scale. J Hand
Surg Am. 2006;31:733-8; discussion 739-40.
27. Dellon AL, Keller KM. Computer-assisted quantitative sensorimotor testing in
patients with carpal and cubital tunnel syndromes. Ann Plast Surg. 1997;38:493.
28. Slutsky DJ. Use of nerve conduction studies and the pressure-specified sensory
device in the diagnosis of carpal tunnel syndrome. J Hand Surg Eur Vol. 2009;34:60-65.
29. Tassler P, Dellon A. Correlation of measurements of pressure perception using the
pressure-specified sensory device with electrodiagnostic testing. Journal of Occupational
and Environmental Medicine. 1995;37:862.
30. Novak CB, Mackinnon SE, Kelly L. Correlation of two-point discrimination and hand
function following median nerve injury. Ann Plast Surg. 1993;31:495.
31. Siemionow M, Zielinski M, Sari A. Comparison of clinical evaluation and
neurosensory testing in the early diagnosis of superimposed entrapment neuropathy in
diabetic patients. Ann Plast Surg. 2006;57:41.
32. Aszmann OC, Dellon AL. Relationship between cutaneous pressure threshold and
two-point discrimination. J Reconstr Microsurg. 1998;14:417-421.
33. Dellon ES, Crone S, Mouery R, Dellon AL. Comparison of the Semmes-Weinstein
monofilaments with the pressure-specifying sensory device. Restorative Neurol Neurosci.
1993;5:323-326.

16
34. Macdermid JC, Richards RS, Roth JH, Ross DC, King GJ. Endoscopic versus open
carpal tunnel release: a randomized trial. J Hand Surg Am. 2003;28:475-480.
35. Cherniack MG, Moalli D, Viscolli C. A comparison of traditional electrodiagnostic
studies, electroneurometry, and vibrometry in the diagnosis of carpal tunnel syndrome. J
Hand Surg Am. 1996;21:122-131.
36. Dellon AL. The vibrometer. Plast Reconstr Surg. 1983;71:427.
37. Gerr F, Letz R, Harris-Abbott D, Hopkins LC. Sensitivity and specificity of
vibrometry for detection of carpal tunnel syndrome. Journal of occupational and
environmental medicine. 1995;37:1108.
38. Lundborg G, Lie-Stenstrom AK, Sollerman C, Stromberg T, Pyykko I. Digital
vibrogram: a new diagnostic tool for sensory testing in compression neuropathy. J Hand
Surg Am. 1986;11:693-699.
39. SZABO RM, Gelberman R, Dimick M. Sensibility testing in patients with carpal
tunnel syndrome. Journal of bone and joint surgery.American volume. 1984;66:60-64.
40. Szabo RM, Gelberman RH, Dimick MP. Sensibility testing in patients with carpal
tunnel syndrome. J Bone Joint Surg Am. 1984;66:60-64.
41. Hubbard MC, MacDermid JC, Kramer JF, Birmingham TB. Quantitative vibration
threshold testing in carpal tunnel syndrome: analysis strategies for optimizing reliability.
J Hand Ther. 2004;17:24-30.

17
42. Novak CB, Kelly L, Mackinnon SE. Sensory recovery after median nerve grafting. J
Hand Surg. 1992;17:59-68.
43. Levine DW, Simmons BP, Koris M, et al. A self-administered questionnaire for the
assessment of severity of symptoms and functional status in carpal tunnel syndrome.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME-. 1993;75:15851585.
44. Mondelli M, Ginanneschi F, Rossi S, Reale F, Padua L, Giannini F. Inter‐observer
reproducibility and responsiveness of a clinical severity scale in surgically treated carpal
tunnel syndrome. Acta Neurol Scand. 2002;106:263-268.
45. Greenslade JR, Mehta RL, Belward P, Warwick DJ. Dash and boston questionnaire
assessment of carpal tunnel syndrome outcome: What is the responsiveness of an
outcome questionnaire? J Hand Surg. 2004;29 B:159-164.
46. Katz JN, Gelberman RH, Wright EA, Lew RA, Liang MH. Responsiveness of selfreported and objective measures of disease severity in carpal tunnel syndrome. Med Care.
1994;32:1127-1133.
47. Jerosch-Herold C, Shepstone L, Miller L, Chapman P. The responsiveness of
sensibility and strength tests in patients undergoing carpal tunnel decompression. BMC
Musculoskeletal Disorders. 2011;12:244.
48. Kim JK, Jeon SH. Minimal clinically important differences in the Carpal Tunnel
Questionnaire after carpal tunnel release. J Hand Surg Eur Vol. 2012.

18
49. MacDermid JC, Doherty T. Clinical and electrodiagnostic testing of carpal tunnel
syndrome: a narrative review. J Orthop Sports Phys Ther. 2004;34:565-588.
50. Galea LA, Mercieca A, Sciberras C, Gatt R, Schembri M. Evaluation of sympathetic
vasomotor fibres in carpal tunnel syndrome using continuous wave Doppler
ultrasonography. J Hand Surg Br. 2006;31:306-310.
51. Pritchard MH, Pugh N, Wright I, Brownlee M. A vascular basis for repetitive strain
injury. Rheumatology (Oxford). 1999;38:636-639.
52. Soejima O, Iida H, Naito M. Measurement of median nerve blood flow during carpal
tunnel release with laser Doppler flowmetry. Minim Invasive Neurosurg. 2001;44:202204.
53. Yayama T, Kobayashi S, Awara K, et al. Intraneural blood flow analysis during an
intraoperative Phalen's test in carpal tunnel syndrome. J Orthop Res. 2010;28:1022-1025.
54. Ozcanli H, Coskun NK, Cengiz M, Oguz N, Sindel M. Definition of a safe-zone in
open carpal tunnel surgery: a cadaver study. Surg Radiol Anat. 2010;32:203-206.
55. Özcan HN, Kara M, Özcan F, et al. Dynamic Doppler Evaluation of the Radial and
Ulnar Arteries in Patients With Carpal Tunnel Syndrome. Am J Roentgenol.
2011;197:W817-W820.
56. CTIA (International Association for the Wireless Telecommunications Industry).
CTIA (International Association for the Wireless Telecommunications Industry).

19
Available at: http://www.ctia.org/consumer_info/service/index.cfm/AID/10323.
Accessed June/20, 2012.
57. Gustafsson E, Johnson PW, Hagberg M. Thumb postures and physical loads during
mobile phone use - A comparison of young adults with and without musculoskeletal
symptoms. Journal of Electromyography and Kinesiology. 2010;20:127-135.
58. Lin I-, Peper E. Psychophysiological patterns during cell phone text messaging: A
preliminary study. Applied Psychophysiology Biofeedback. 2009;34:53-57.
59. Berolo S, Wells RP, Amick 3,Benjamin C. Musculoskeletal symptoms among mobile
hand-held device users and their relationship to device use: A preliminary study in a
Canadian university population. Appl Ergon. 2011;42:371-378.

20

Chapter 2

2

The Construct Validity, Clinically Important Differences, and
Responsiveness of Symptom Severity Scores, and Sensory Tests in Patients
with Carpal Tunnel Syndrome
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2.1

Introduction

Carpal Tunnel Syndrome (CTS) is a common compression neuropathy with an annual
prevalence ranging between 2.7% in Sweden 1 to 6.7% in the United States of America. 2
Incidences of Carpal Tunnel Syndrome can vary depending on the type of the occupation.
In 1988 and 2010, industry related jobs (for example, manufacturing and food services),
contributed to the majority of work related CTS cases in the United States of America
based on National Health Surveys.

2, 3

For workers employed within educational

institutions, a lower prevalence of CTS injury was found. 2 CTS is a major contributor to
occupational upper extremity disorders,

4, 5

and is associated with considerable health

care costs. 6
Typical sensory symptoms experienced by patients with CTS are tingling, pain, and
numbness at night or throughout the day; with advanced stages of the disease affecting
motor function and dexterity.

7-12, 12-14

A number of clinical tests are performed to

evaluate hand function in patients with CTS,
specific questionnaires.

22

15-20

such as sensory tests,

21

or disease

These clinical tests can help clinicians determine if a patient

responded to treatment; and if carpal tunnel release is required.

15

The Clinically

Important Difference (CID) is a measurement property for responsiveness that indicates
the change scores on an outcome measure that is considered to provide important
information for a clinician or patient for deciding the next step in a treatment protocol.
This CID could be used to discriminate patients who make clinically important changes;
indicating a clinical improvement following treatment. Studies that identify CID must
divide patient responses as clinically important versus clinically unimportant to determine
the optimal cut-off. Thus, an external criterion on another outcome measure must be
used to make this judgment. A variety of methods can be used as an external criterion to
determine whether a patient has made a clinically important change. As for patients with
CTS, if symptoms resolve with conservative treatment, this could be considered an
external criterion for demonstrating clinical improvement. If symptoms continue despite
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conservative treatment, the patient did not experience a clinical important change, and
surgery would be the next treatment option. The Symptom Severity Scale (SSS) is a
commonly used self-reported questionnaire designed specifically for evaluating
symptoms in CTS. 22 The CID of the SSS is equal to 1.04 or 1.14, depending whether the
treatment method is by steroid injection 23, 24 or with carpal tunnel release 25 respectively.
However, the CID for orthotic intervention has not been identified in literature or
identified for clinical practice.
In addition, sensation is an important component of hand function,

19, 26

and is typically

impaired in CTS. Sensory testing is important to assist clinicians in the diagnosis of
CTS; to determine severity; or to monitor improvements with treatment. A variety of
tools can provide quantitative measures of sensory threshold for different modalities,
including touch and vibration threshold.

15-17, 19

Two sensory tools which are often used

in clinical studies to measure sensory characteristics are the Pressure Specified Sensory
Device (PSSD) (NK Biotechnical Corporation, Minneapolis, MN, USA) and the
Vibrometer (Z tech Medical, Salt Lake City, UT, USA). Some clinical measurement
properties of the PSSD and Vibrometer have been reported. The PSSD has been shown
to have high reliability (r= 0.95) and interrater reliability in healthy persons for one point
static testing (r= 0.99).

27

The Vibrometer has excellent test-retest reliability in patients

with CTS with intraclass correlation coefficients (ICCs) ranging from 0.86 to 0.89.

28

However, there is limited evidence about the discriminative and evaluative properties of
sensory measures - in particular to touch and vibration threshold tools. There is a specific
deficit of knowledge about the CID of sensory tools, which is a substantial gap in clinical
knowledge since this is the measure that would be relevant for clinical decision making
regarding whether patients have made clinically relevant improvements.
The purpose of this study was to evaluate the clinical measurement properties of the
Vibrometer and the PSSD and self-reported measures of symptoms severity in patients
with CTS, in terms of the following:
1. The convergent construct validity in relation to measures of self-reported and
performance-based hand function (DASH and NK Dexterity).
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2. The CID of the SSS (established by comparison to the external criterion of failure to
achieve symptom relief as indicated by progression to surgery).
3. The CID of the Vibrometer and PSSD.
4. The responsiveness of the Vibrometer and PSSD in patients who achieved a
clinically important improvement in symptoms.

2.2

Methods

All patients were recruited from a tertiary care center specializing in upper limb
disorders. Patients were diagnosed with CTS based on a clinical diagnosis made by the
treating hand surgeons and confirmed by electromyography (EMG) based on the latest
version of the American Association of Electrodiagnostic Medicine criteria as outlined by
consensus criteria by Rempel et al. 14 Patients were included in the study if they had mild
CTS, as conservative management is appropriate for this particular category of the
disease. 29 Patients were excluded from the study if they met any of the following criteria:
Exclusion Criteria:


Urgent or severe CTS requiring early operative intervention;



Pregnancy 30-32;



Concurrent injury to the upper extremity including recent trauma (i.e. fracture,
amputation, tumor, or nerve compression);



Wrist arthritis, rheumatoid arthritis, diabetes mellitus, or thyroid disease;



Inability to complete study forms/assessments; and



Neurological conditions
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This study was approved by the university research ethics board and informed consent
was obtained from each patient.
Sample size justification. The sample size was determined for the correlation between
sensory tools and SSS, DASH, and Dexterity to achieve significance using G*Power
version 3.1.4 software
(http://www.psycho.uni-duesseldorf.de/abteilungen/aap/gpower3/download-and-register)
at a power of 80% with a correlation of 0.5 with a bivariate normal model. Alpha was set
at 0.05 using a 2 tail test. The minimum sample size required was 29 patients. Statistical
significance was considered if p<0.05.

2.3

Outcome measures.

Pressure specified sensory device (PSSD). The PSSD is a computerized touch
threshold device, which can measure the minimum amount of pressure required to
elicit a response from a subject (g/mm2), as well as spatial discrimination (2 Point
Discrimination) (2PD). It has a range of 0.1 to 100 g/mm2. Each hemispheric
prong has an area of 0.90mm2. This study tested touch threshold only with the
PSSD. For touch threshold of a single point, the tester applied an individual
metallic prong from the PSSD device into the distal pulp of the long finger in the
affected hand while the participant sat with eyes closed. Participants were
instructed to push a trigger held in the opposite hand, to identify when they
perceived the stimulus. The PSSD has been shown to have high reliability (r=
0.95) and intertest reliability in patients with neuropathy for one point static
testing (r= 0.99). 27 For each visit, a total of five repetitions were taken; the lowest
and highest scores were dropped and the remaining three were averaged as
recommended by the manufacturer. A total of three visits were required.
The vibrometer. The Vibrometer is a sensory modality which measures vibration
perception threshold. 33 The Vibrometer used in this study is a 50 Hz computercontrolled ramped protocol where the vibration stimuli are applied through a 2mm
diameter aperture with a 1mm diameter vibrating post. Subjects were required to
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identify when they felt a stimulus by squeezing a handheld trigger with their eyes
closed. The minimum score is 1 um and the maximum score is 180um. A
ramped protocol is regulated by the device supplying sufficient repetitions of test
stimuli; to achieve a stable estimate of vibration threshold. The Vibrometer has
shown excellent test retest reliability in patients with CTS with ICCs ranging from
0.86 to 0.89. 28 The Vibrometer was tested once at each follow up point and for a
total of 3 times.
The symptom severity scale (SSS). The SSS is a disease specific questionnaire
composed of 11 questions each rated 1 through 5 that measures symptoms
experienced in a typical 24 hour period within the past 2 weeks. Respondents rate
the severity of CTS-related symptoms and disability with scores ranging from 1
(no symptoms) to 5 (worst). 22 The final score for the SSS is calculated as a mean
of 11 questions. It has been assessed and found to be valid for face, content, and
construct validity in measuring clinically relevant change in patients with Carpal
Tunnel Syndrome. 22, 34-36 It has also been shown to be reliable for test-retest
reliability. 22, 37 The questionnaire was completed once per visit and patients were
required to complete the questionnaire a total of 3 times.
Disability of the arm, shoulder, and hand (DASH) questionnaire. The DASH
is a self–report measure which allows patients to rate the disability of their arm,
shoulder and hand. 38 Responses range from 1 to 5, with a higher score indicating
higher levels of pain and disability. The questionnaire has been shown to be
responsive after Carpal Tunnel Release surgery. 39 The convergent, construct, and
discriminatory validity has been supported for distal upper extremities, including
Carpal Tunnel Syndrome. 40 DASH has also been found to be responsiveness to
clinical change. 40 The questionnaire was completed once per visit and patients
were required to complete the questionnaire a total of 3 times.
NK dexterity small objects test. The NK Dexterity Small Objects Test (referred
to as “Dexterity” for short) is a test of manual dexterity which measures the
amount of time (in seconds) that is required for a patient to move objects on a
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plastic board. 41, 42 Sizes of the objects are classified as small, medium, or large.
It consists of plastic and metal objects that need to be moved with the affected
hand and placed into another location. Timing was initiated from the moment the
hand moved from the starting position towards the first object until subjects
removed their hand from the final object. For this study, dexterity testing was
done with the small objects only because fine motor function is expected to be
most affected in CTS. 41 In addition, the small object subtest has been shown to
have the best correlation to hand function with r = 0.47-0.87; and also has high
reliability (ICC = 0.53-0.86). 41, 42 The time recorded for the patient to complete
the dexterity task was the mean of 3 trials at each follow up point.

2.4

Procedure

Each patient was treated with night orthotic intervention of the wrist in neutral position
for 12 weeks; and had assessments at baseline, 6 weeks, and 12 weeks later. If patients
and surgeons felt that orthotic intervention was not reducing symptoms, then surgery was
offered. Patients were monitored for a year following the intervention to determine
whether they proceeded to surgery.
At baseline and at each follow up visit, patients completed the following assessments:
PSSD, Vibrometer, SSS, DASH, and Dexterity. Data for the PSSD and Vibrometer were
collected by having each patient seated with their affected arm supported on a table. For
the PSSD, the wrist was supported by a piece of foam, such that the wrist was in neutral
position and the palm was facing upwards. Data for the Vibrometer was collected by
having the arm rest directly on the table with the hand in pronated position. The long
finger was used for testing sensation in both PSSD and Vibrometer testing. Testing was
done on the affected hand if CTS was affecting only one side; otherwise, the hand with
more severe symptoms was tested for subjects who had CTS in both hands.

2.5

Analysis

All analyses were performed using SPSS software version 19. Data were checked for
normality 43, 44 by checking the skewness ratio for each outcome measure were between ±
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2.

44, 45

The Shapiro-Wilk test was also evaluated to determine if data were normal as a

verification process. If p>0.05, the data are normally distributed. Otherwise, if p<0.05,
the data are not normally distributed.

44

The data were not normally distributed (p<0.05),

thus non-parametric statistics were used for correlations.
Cross-sectional convergent validity. Cross Sectional Convergent Validity
assesses the extent to which a measure’s result agrees with another measure that is
believed to be assessing the same or similar attribute.

46

The correlation between

the PSSD and the Vibrometer to measures of hand function were determined
using Spearman’s correlation (rs) since the data were not normally distributed.
Interpretation was based on the guidelines that Spearman’ correlation are
considered poor if rs< 0.25, considered moderate if rs = 0.25 - 0.50, considered
good if rs = 0.50 - 0.75 and considered excellent if rs > 0.75. 43
Calculating clinically important difference (CID) for SSS. The CID was
determined using Receiver Operating Characteristic (ROC) curves to determine
the cutoff point to dichotomize and categorize the sample into 2 groups. The first
criterion to determine if an important change occurred was based on patients
proceeding toward surgery. The SSS was used to determine a cut-off score to
discriminate clinically important change. The patients were categorized either as
responders (those who responded to orthotic intervention and did not proceed to
surgery) or non-responders (those who did not respond to orthotic intervention
and proceeded to surgery).
The final follow-up visit was based on scores at 12 weeks. For patients (n = 21
for the PSSD and n = 22 for the Vibrometer) who did not return for their final
follow-up, the score at 6 weeks was carried forward as it represented the last
known status; and our previous studies have shown that patients who are going to
respond to treatment will do so within the first six weeks.

24

ROC curves were

used to establish the discriminative ability of the cut-off score; and to determine
the optimized cut-off.

ROC curves plotted sensitivity (y-axis) versus 1 –

specificity (x-axis). For the ROC curves for the SSS, sensitivity is defined as the
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number of patients who achieved a change score that was less than the cut off
divided by all those who proceeded to surgery. Specificity refers to the number of
patients who achieved a change greater than the cut-off score divided by those did
not proceed to surgery. Whereas for the sensory tools, sensitivity is defined as the
number of patients who did not achieve an important change divided by those
who achieved a change score less than the cut off on the SSS. Specificity refers
to the number of patients who achieved an important change divided by those
who had scored more than the cut off on the SSS. The most efficient cut off score
is the point closest to the top left corner of the ROC curve. If the area under the
curve (AUC) is equal or less than 0.50, this would mean the curve is no better
than chance to discriminate patients. Generally, an area under the curve > 0.75 is
considered to be clinically useful. 47
Calculating clinically important difference (CID) for the vibrometer and
PSSD. Once the CID was calculated for the SSS, this cut score was used to
determine the CID of the two sensory tools. ROC curves were used to establish
the discriminative ability of the cut score and the optimized cut off. If the area
under the curve (AUC) is equal or less than 0.50, this would mean has no better
than chance ability to discriminate.
Responsiveness. Responsiveness is the ability of a tool to measure a clinically
important change that is noticeable to the patient or the clinician.

48

broad methods of determining clinically meaningful change:

There are two
anchor and

distribution-based approaches. Both were used in this study.
Anchor based methods define clinically important change based on an external
anchor,

49

which can be based on a subjective opinion (from a clinician’s or

patient’s perception) or from an objective measures (such as a disease specific
tool).

49

The anchor must be clearly defined and be able to show clinically

important difference between groups at one instant (cross sectional approach) or
over a period of time (longitudinal approach).

50

Often, a global rating of change

is used to determine subjective change. Although this method is easy to apply, it
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is subject to recall bias. The use of a disease specific tool is more accurate to
measure important change because it is a standardized tool in clinical practice.
This study used the SSS as the external anchor.
Distribution based methods focus on statistical properties of a tool for measuring
clinically important change.

50

There are three approaches of distribution based

methods (statistical significance, sample variation, and measurement precision),
but only sample variation will be explained for the case of this paper. One of the
more common methods of measuring sample variation are Effect Size (ES) and
Standardized Response Mean (SRM).

These are the two distribution based

methods used in this study. The ES was calculated by dividing the mean change
by the standard deviation of baseline scores.

51

The SRM was calculated by

dividing the mean difference of the change scores by the standard deviation of
change. 52
The SRM and ES were calculated for both the responder group and the nonresponder groups for the SSS, the PSSD, and the Vibrometer based on the CID’s
established in this study for the SSS. The change scores were calculated in the
same way when determining the CID for the SSS, PSSD, and Vibrometer.
Responsiveness was defined as low if SRM and ES were < 0.5, moderate if SRM
and ES were between 0.5 to 0.8 and large responsiveness if ≥ 0.8. 53, 5437

2.6

Results

A total of 73 patients (20 men and 53 women) were eligible for inclusion in this study.
Patients were between the ages of 29 to 74 years (mean age of 49 ± 9 years). The
duration of the symptoms ranged from 1 month – 30 years (mean 4 ± 6 years) (See Table
1). Tables with baseline and follow up scores for PSSD, Vibrometer, DASH, SSS, and
Dexterity are shown in Table 2. Only 63 patients out of 73 patients completed the SSS.
From this group of 63 patients, 38 patients completed the PSSD, and 22 completed
testing with the Vibrometer for both baseline and final follow up. The SSS, PSSD, and
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the Vibrometer had 2, 1, and 5 patients respectively who had their scores at 6 weeks
carried forward to 12 weeks.
The Vibrometer demonstrated moderate correlations to symptoms and dexterity at most
follow-up assessments; and was more strongly related to these tools than was the PSSD
(Table 3). The Vibrometer had low to moderate correlations with the SSS (r = 0.22 –
0.41) and moderate correlations with Dexterity (r = 0.36 – 0.41) (Table 3). The PSSD
demonstrated low correlation to both SSS (r = 0.22 – 0.32) and Dexterity (r < 0.32)
(Table 3). Neither sensory measure correlated significantly to the DASH (r = 0.09 –
0.30) (Table 3). The SSS demonstrated moderate correlation to dexterity; and a large
correlation to the DASH (0.63 – 0.76) (Table 3).
The CID for the change in the SSS that best differentiated response to orthotic
intervention was 0.5 points (86% sensitivity; and 54% specificity); with an area under the
curve of 0.73 (0.60, 0.86) (Figure 1 and Table 4). The CID for the PSSD was equal
0.15g/mm2 (60% sensitivity; and 39% specificity) with an area under the curve of 0.46
(0.27, 0.64) (Figure 2). The ROC curve for the Vibrometer could not be graphed because
all 22 individuals improved at least 0.5 points on the SSS and the cut-off point did not
provide any values for the x axis for 1-specificity (Table 5).
The SSS demonstrated expected large responsiveness for responders (SRM= 2.18 (±0.42)
and ES = 1.40 (±0.42)) and low responsiveness for non responders (SRM = 0.15(±0.31)
and ES = 0.08 (±0.25)) (Table 5). The PSSD demonstrated low responsiveness for both
responder (SRM = 0.09 and ES = 0.08) and non responder (SRM = 0.04 and ES = 0.06)
(Table 6). The Vibrometer demonstrated moderate responsiveness for responders (SRM=
0.61 and ES = 0.46) to treatment and low responsiveness for non responders (SRM =
0.18 and ES = 0.12) (Table 6).
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Table 2.1: Demographic information of patients
Total Number of Participants

73

Number of Males

20

Number of Females

53

Mean Age and Range

49 ± 9 years (29 – 74
years)

Symptoms Duration

4 ± 6 years (1 month – 30
years)

Left Hand Affected:

10

Right Hand Affected

25

Both Hand Affected

38

Heart Problems

7

Diabetes

5

Arthritis:

26

WSIB Compensation cases:

18 with 4 pending

WSIB = Workplace Safety Insurance Board
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Table 2.2: Baseline descriptive data
PSSD

Vibrometer

DASH

SSS

Dexterity
Small
Objects
Test

Mean (SD)

6.36 (7.62)

28.16 (28.66)

35.63

3.04 (0.75)

(18.25)

49.17
(15.74)

Median

4.40 (3.38,

19.00 (10.75,

33.33

3.00 (2.45 ,

44.00 (40.00,

(25th and

5.90)

39.

(23.33,

3.64)

53.00)

-0.027

2.35 (0.31)

75th

47.29)
25)

percentile)
Skewness

4.02 (0.38)

2.56 (0.31)

0.66 (0.28)

(Standard

(0.29)

Error)
Kurtosis
(Standard
Error)

17.65 (0.75)

8.03 (0.62)

0.282 (0.56)

-0.64 (0.60)

6.62 (0.61)
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Table 2.3: Spearman correlation between sensory and symptoms severity scores
and their functional measures
Tools

DASH

SSS

Dexterity

Time

PSSD

Vibrometer

SSS

rs (95%CI)

rs (95%CI)

rs (95%CI)

Baseline

0.09±0.32

0.13±0.25

0.63±0.14*

6 weeks

0.31±0.30

0.21±0.27

0.74±0.14*

12 weeks

0.10±0.27

0.22±0.27

0.76±0.13*

Baseline

0.22±0.31

0.41±0.25*

6 weeks

0.32±0.30*

0.22±0.27

12 weeks

0.25±0.27

0.35±0.27*

Baseline

0.20±0.31

0.36±0.25*

0.32±0.25*

6 weeks

0.32±0.30*

0.41±0.27*

0.53±0.21*

12 weeks

-0.02±0.27

0.39±0.27*

0.59±0.20*

1.0

PSSD = Pressure Specified Sensory Device. DASH = Disability of the Arm, Shoulder,
and Hand. SSS = Symptom Severity Scale.
* Correlation is significant at p<0.05
Confidence intervals were calculated with http://vassarstats.net/rho.html.
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Table 2.4: Information on the ROC curves produced
Figure1: ΔSSS
n = 62

ΔVibrometer

Figure 2:
ΔPSSD
n=38

External Criterion

Failed to sufficiently
resolve symptoms-

n=55

Failed to sufficiently resolve symptoms –
based on
ΔSSS = 0.5

proceed to surgery
0.50

0.15

undefined

0.73 (0.60 – 0.86)

0.46 (0.27-0.64)

n/a

Sensitivity

0.86

0.60

0%

Specificity

0.54

0.39

100%

Cut point for CID
Area under the
curve

ROC = Receiver Operating Characteristic. CID = Minimally Clinically Important
Difference. ΔSSS = change in SSS scores. ΔPSSD = change in PSSD scores.
ΔVibrometer = change in Vibrometer scores. CID for Vibrometer was undefined because
all who completed both Vibrometer and SSS did not proceed to surgery. Non responders
for Vibrometer were because they did not complete SSS.
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Table 2.5: Change scores for the SSS and responsiveness based on proceeding to
N

SSS Score

Mean Baseline Score

Mean Post

Mean

SRM

ES

(SD)

Treatment

Change

(95%CI)

(95%CI)

Score (SD)

(SD)

2.70 (0.89)

0.32 (0.64)

0.50

0.67

(±0.24)

(±0.24)

2.18

1.40

(±0.42)

(±0.42)

0.15

0.08

(±0.31)

(±0.31)

62

3.03 (0.75)

Overall

SSS Score

22

3.03(0.70)

2.05(0.73)

0.98(0.45)

Responder
s (Δ ≥
0.50)

SSS Score

39

3.02 (0.79)

3.08 (0.759)

0.06(0.39)

Non
Responder
s (Δ <
0.50)
surgery
SD = Standard Deviation. PSSD = Pressure Specified Sensory Device. DASH =
Disability of the Arm, Shoulder, and Hand. SSS = Symptom Severity Scale. CI =
Confidence Interval
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Table 2.6: Responsiveness for the PSSD, and vibrometer based on CID of change
score SSS = 0.5
N

Mean Baseline

Mean Post

Mean

SRM

Score (SD)

Treatment

Change (SD)

(95%CI)

ES
(95%CI)

Score (SD)
PSSD

15

4.13 (1.99)

3.83 (3.53)

0.30 (3.26)

0.09

0.08
(±0.51)

Responder
(±0.51)
PSSD Non

23

7.82(9.47)

7.30(15.29)

0.53(13.48)

0.04

0.06

(±0.41)

(±0.41)

0.61

0.46

(±0.41)

(±0.41)

0.18

0.12

(±0.34)

(±0.34)

Responder

Vibrometer

22

25.55(19.51)

16.64(14.46)

8.91(14.70)

Responder

Vibrometer
Non

33

27.39 (32.10)

23.39 (29.89)

4.00 (21.81)

Responder
SD = Standard Deviation. SRM = Standardized Response Mean. ES = Effect Size.
PSSD = Pressure Specified Sensory Device. DASH = Disability of the Arm, Shoulder,
and Hand. SSS = Symptom Severity Scale. CI = Confidence Interval. The overall ES of
all patients was calculated to indicate the overall response to orthotic intervention; SRM
and ES were determined for responders and non-responders to indicate responsiveness.
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2.1: Receiver Operating Characteristic Curve for Determining the Cut-off Point to
Determine Responder and Non Responder Subgroups Based on the SSS
Circle represents cut point for Clinically Important Difference.
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Figure 2.2: Receiver Operating Characteristic Curve for Determining the Cut-off
Point to Determine a Clinical Important Change for the PSSD based on the CID of
0.5 for the SSS.
Circle represents cut point for Clinically Important Difference.
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2.7

Discussion

The current study provides estimates of self-report and sensory measures used in outcome
assessment of CTS that support the use of the SSS and Vibrometry. This current study
demonstrated that the CID of the symptom severity scale is smaller than has been
previously established with reference to a surgical intervention. 25 Previous studies have
suggested that a one-point difference 23, 25 was clinically important; whereas our study
suggested that a 0.50 change was clinically important. Since the SSS is a five point scale;
a one-point difference represents a 20% improvement; whereas 0.5 represents a 10%
improvement. These differences can be partially attributed to differences in the effect
size of the two interventions since we know that surgery provides greater change in
symptoms compared to conservative management. 55 For this reason, it is important to
establish a CID for conservative management that could be used by therapists when
assessing the response to orthotic intervention.
The ROC curve in Figure 1 has shown that the CID for the SSS is 0.5. However, this
value is much lower than the CID determined by Ozyurekoglu et al, 23 which was 1.04.
Potential differences between the studies may stem from differences in treatment type
and the severity of cases in both studies. This current study used orthotic intervention for
chronic cases of CTS, whereas in Ozyurekoglu et al’s study, 23 cortisone injections were
used for treatment and the patients were suffering from acute cases of CTS. In terms of
the method of reported change, our study used the SSS to measure patient self -reported
change after determining whether they should proceed to surgery or not. Ozyurekoglu et
al 23 calculated the CID for the SSS based on a global rating of change as the external
anchor for patients to determine improvement. The Global Rating of Change has been
criticized because of recall bias from the patient, 56 which may overestimate or
underestimate the effect of the treatment. Our study determined the CID for the SSS
based on the anchor of proceeding to surgery which combines a shared decision by both
clinician and patient. We also used distribution-based methods to illustrate
responsiveness, which has shown that the SSS is responsive to clinical change (Table 5).
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This study supports the discriminative ability of the SSS, although there are limitations
inherent in the measurement properties of the SSS, and in this study. The estimate of
CID at 0.5 is subject to imprecision as the lower end of the interval is below 0.75, 47
although the confidence interval indicates discrimination may be as high as 0.86. The
AUC indicates that the SSS would be more useful than the PSSD or the Vibrometer for
discriminating patients with a CID. In practice, it would be useful to set treatment goals
to achieve a CID of 0.5 on the SSS or greater. However, since the specificity of this cutoff was lower than sensitivity, therapists should expect some patients who improve more
than 0.5 and would still proceed to surgery despite having improved symptoms (Table 5
and Table 6). The tool’s CID has a higher probability to send a patient toward surgery
rather than not.
Our study also had used the external criteria of proceeding to surgery rather than using a
global rating of change 23 compared to Ozyurekoglu et al’s study. The external criterion
of proceeding to surgery was decided by a clinician on the presentation of symptoms
which patients still experienced despite orthotic intervention. However, patients may still
choose not to go for surgery despite when a clinician is in favour of surgery. The SSS
was used as an external criteria for the PSSD because the SSS is a self -reported and
disease specific outcome measure, which would a patient to have a role within the
decision making process of deciding or not to proceed to surgery under a standardized
process. The global rating of change is subject to recall bias and variability 57, 58 by the
patient, and it may not accurately determine the best clinical decision for the patient. The
SSS overcomes the issues of reliability and recall bias that the global rating of change
may have. This study incorporates both clinician’s and patient’s input in the treatment
process of determining the clinically important difference on the SSS.
Comparing the performance of our two sensory tests, we suggest that the Vibrometer
scores provided more clinically useful indicators than did the PSSD. The Vibrometer
was more responsive based on both anchor and distribution based estimates of
responsiveness. The correlations between measures were more consistent with the
expected relationships of sensory function to hand function for the Vibrometer in
comparison to the PSSD. The PSSD and Vibrometer did not discriminate to the extent
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thought useful in clinical practice; in fact the PSSD was no better than chance because
the area under the ROC curve was crossing the 0.5 mark (Table 5 and 6). The
Vibrometer did not provide a defined cut score, as all patients had improved at least 0.5
on the SSS. A larger sample size of patients could be recruited for future studies to
increase the number of failures from orthotic intervention to allow for a cut score to be
determined. Clinicians should be aware that the PSSD and Vibrometer may not be useful
for clinical decisions about whether their patients have made clinically important
improvements. Since that the Vibrometer shows more promise, the next steps would be
to perform more detailed analysis about the use of Vibrometer scores in clinical decisionmaking. Although we did not find the PSSD useful for evaluating clinical change, others
have reported it useful in diagnosis of nerve entrapment syndromes. 59 The PSSD is a
very sensitive tool for diagnosing CTS, cubital tunnel syndrome, tarsal tunnel syndrome,
and common peroneal nerve entrapment, all having highest sensitivity possible (100%),
but low specificity ranging from 0 – 33%.

59

The PSSD was reported to be more

sensitive than standard electrodiagnosis, which is a standard method for diagnosing
neuropathy (which had sensitivity ranging between 37% - 89% depending on the type of
neuropathy.) 59 The PSSD would be able to detect neuropathies even when the standard
method cannot in patients suspected of having neuropathy.
The correlation between the sensory measures and the DASH did not match our a priori
expectations. We expected that sensory function should contribute to hand function and
be reflected in this measure because the DASH has questions specifically regarding
numbness and tingling, and it has been validated for the CTS population. 60 Correlations
were generally higher with the SSS which suggest that the SSS is a better indicator of
sensory nerve function than the DASH. In addition, the DASH does not contain specific
questions on touch or vibration threshold, so this may contribute to the low correlations
between sensory threshold tests and DASH.
The SSS was found to have moderate correlations with dexterity small objects test, and
good to excellent correlations 61 with DASH. Our correlation between the SSS and
DASH is similar to the results found in a study on the validation of the Turkish version of
the Quick DASH to the SSS in patients with CTS. 60 This paper found that the Quick
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DASH had a high correlation between the disability/symptom and work subscales with
the SSS (r = 0.63-0.68). Our current study and the study by Dogan et al 60 both reinforce
that the DASH is a valid tool for the evaluating patients with CTS. In terms of the
correlation between dexterity and symptom severity, the moderate correlation indicates a
proportional relation between symptoms severity and the impairment to hand dexterity.
Our study had similar findings to a kinematic study 61 comparing the variability in the
precision of pinching tasks in 16 age and gender matched patients with CTS and healthy
controls. Gehrmann et al 61 found that patients with CTS had more variability in their
pinching movements compared to the controls. Regardless of methodology, both our
studies suggest that CTS impairs hand dexterity.
Our study results had some limitations. Most important of these is that the sensory tests
were performed by a trained experienced independent evaluator, not by a hand therapist.
Independent evaluators may have been less skilled than hand therapists in sensory testing.
However, even experienced hand therapists do not always agree on touch threshold
measures in CTS patients. 16, 17 The PSSD is a hand-held device and may be more subject
to error than the Vibrometer. Brakel et al 62 found that evaluator experience in sensory
testing can influence inter-tester reliability. The study examined the inter tester reliability
in sensory testing between five physiotechnicians and nurse/paramedical workers in a
sample of patients with leprosy. Physiotechnicians had significantly higher weighted
kappa values with touch threshold testing (kappa = 0.98 versus 0.89) compared to whole
group. 62 This difference might be explained because physiotechnicians were more
experienced in sensory testing than nurse/paramedical workers. 62 In contrast, the
Vibrometer is an automated ramped protocol and uses multiple applications of a vibrating
stimulus. Hence, skill may have been less importance for this tool, so that the random
error may be reduced. Our study also had small groups tested for each sensory tool as a
limitation to the study. We had some tests which were not completed for each patient
when they came for their visit. These small sample sizes may have resulted in increased
type II error of the correlations found between the sensory tools and functional measures.
For example, the PSSD was unable to achieve a significant correlation with other tools.
We would need to be more consistent during data collection to complete outcome
measures for all patients coming into the study.
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2.8

Conclusion

This study suggests that the Vibrometer is a better choice for evaluating sensation to
represent overall hand function. The CID of 0.5 on the SSS from orthotic intervention
may be useful for setting treatment goals. Sensory tools should not be used in isolation to
make decisions about clinical improvement in CTS. Despite the common use of sensory
evaluation, there remains a large gap in our knowledge of the clinical measurement
properties of different tools and test protocol variations. Future studies should address
how clinical decisions are made based on sensory measures and whether sensory tools are
important measures in evaluating the prognosis of patients.

44

2.9

References

1. Atroshi I, Gummesson C, Johnsson R, Ornstein E, Ranstam J, Rosén I. Prevalence of
carpal tunnel syndrome in a general population. JAMA: the journal of the American
Medical Association. 1999;282:153.
2. Luckhaupt SE, Dahlhamer JM, Ward BW, Sweeney MH, Sestito JP, Calvert GM.
Prevalence and work-relatedness of carpal tunnel syndrome in the working population,
United States, 2010 national health interview survey. Am J Ind Med. 2012.
3. Tanaka S, Wild DK, Seligman PJ, Halperin WE, Behrens VJ, Putz-Anderson V.
Prevalence and work-relatedness of self-reported carpal tunnel syndrome among U.S.
workers: Analysis of the Occupational Health Supplement data of 1988 National Health
Interview Survey. Am J Ind Med. 1995;27:451-470.
4. Zakaria D. Rates of carpal tunnel syndrome, epicondylitis, and rotator cuff claims in
Ontario workers during 1997. Chronic Dis Can. 2004;25:32-39.
5. Zakaria D, Robertson J, MacDermid J, Hartford K, Koval J. Work‐related cumulative
trauma disorders of the upper extremity: Navigating the epidemiologic literature. Am J
Ind Med. 2002;42:258-269.
6. Feuerstein M, Miller VL, Burrell LM, Berger R. Occupational upper extremity
disorders in the federal workforce: prevalence, health care expenditures, and patterns of
work disability. Journal of Occupational and Environmental Medicine. 1998;40:546.

45
7. Werner RA, Andary M. Carpal tunnel syndrome: pathophysiology and clinical
neurophysiology. Clinical Neurophysiology. 2002;113:1373-1381.
8. Kerwin G, Williams CS, Seiler 3rd J. The pathophysiology of carpal tunnel syndrome.
Hand Clin. 1996;12:243.
9. Gerritsen AAM, de Vet HCW, Scholten RJPM, Bertelsmann FW, de Krom MC,
Bouter LM. Splinting vs surgery in the treatment of carpal tunnel syndrome. JAMA: the
journal of the American Medical Association. 2002;288:1245.
10. Gerritsen AA, de Krom MC, Struijs MA, Scholten RJ, de Vet HC, Bouter LM.
Conservative treatment options for carpal tunnel syndrome: a systematic review of
randomised controlled trials. J Neurol. 2002;249:272-280.
11. Gerritsen AA, de Vet HC, Scholten RJ, van Tulder MW, Bouter LM. Enabling metaanalysis in systematic reviews on carpal tunnel syndrome. J Hand Surg Am. 2002;27:828832.
12. Gerritsen AA, Uitdehaag BM, van Geldere D, Scholten RJ, de Vet HC, Bouter LM.
Systematic review of randomized clinical trials of surgical treatment for carpal tunnel
syndrome. Br J Surg. 2001;88:1285-1295.
13. Gerritsen AAM, De Vet HCW, Scholten RJPM, Bertelsmann FW, De Krom
MCTFM, Bouter LM. Greater clinical effects on carpal tunnel syndrome with surgery
than with splinting; results of a randomised clinical trial. Ned Tijdschr Geneeskd.
2002;146:2153-2156.

46
14. Rempel D, Evanoff B, Amadio PC, et al. Consensus criteria for the classification of
carpal tunnel syndrome in epidemiologic studies. Am J Public Health. 1998;88:1447.
15. MacDermid J. Accuracy of clinical tests used in the detection of carpal tunnel
syndrome: a literature review. Journal of Hand Therapy. 1991;4:169-176.
16. MacDermid JC, Kramer JF, Roth JH. Decision making in detecting abnormal
Semmes-Weinstein monofilament thresholds in carpal tunnel syndrome. J Hand Ther.
1994;7:158-162.
17. MacDermid J, Kramer J, McFarlane R, Roth J. Inter-rater agreement and accuracy of
clinical tests used in diagnosis of carpal tunnel syndrome. Work. 1997;8:37-44.
18. MacDermid JC, Doherty T. Clinical and electrodiagnostic testing of carpal tunnel
syndrome: a narrative review. J Orthop Sports Phys Ther. 2004;34:565-588.
19. MacDermid JC, Wessel J. Clinical diagnosis of carpal tunnel syndrome: a systematic
review. Journal of Hand Therapy. 2004;17:309-319.
20. Thonnard JL, Saels P, den Bergh PV, Lejeune T. Effects of chronic median nerve
compression at the wrist on sensation and manual skills. Experimental brain research.
1999;128:61-64.
21. Bell-Krotoski J, Weinstein S, Weinstein C. Testing sensibility, including touchpressure, two-point discrimination, point localization, and vibration. Journal of hand
therapy: official journal of the American Society of Hand Therapists. 1993;6:114.

47
22. Levine DW, Simmons BP, Koris M, et al. A self-administered questionnaire for the
assessment of severity of symptoms and functional status in carpal tunnel syndrome.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME-. 1993;75:15851585.
23. Ozyurekoglu T, McCabe SJ, Goldsmith LJ, LaJoie AS. The minimal clinically
important difference of the Carpal Tunnel Syndrome Symptom Severity Scale. J Hand
Surg Am. 2006;31:733-8; discussion 739-40.
24. Boyd KU, BING SGAN, Ross DC, Richards RS, Roth JH, MacDermid J. Outcomes
in carpal tunnel syndrome: symptom severity, conservative management and progression
to surgery. Clinical and investigative medicine. 2005;28:254-260.
25. Kim JK, Jeon SH. Minimal clinically important differences in the Carpal Tunnel
Questionnaire after carpal tunnel release. J Hand Surg Eur Vol. 2012.
26. Thonnard JL, Saels P, den Bergh PV, Lejeune T. Effects of chronic median nerve
compression at the wrist on sensation and manual skills. Experimental brain research.
1999;128:61-64.
27. Dellon AL, Keller KM. Computer-assisted quantitative sensorimotor testing in
patients with carpal and cubital tunnel syndromes. Ann Plast Surg. 1997;38:493.
28. Hubbard MC, MacDermid JC, Kramer JF, Birmingham TB. Quantitative vibration
threshold testing in carpal tunnel syndrome: analysis strategies for optimizing reliability.
J Hand Ther. 2004;17:24-30.

48
29. Alfonso C, Jann S, Massa R, Torreggiani A. Diagnosis, treatment and follow-up of
the carpal tunnel syndrome: a review. Neurol Sci. 2010;31:243-252.
30. Massey EW. Carpal tunnel syndrome in pregnancy. Obstet Gynecol Surv.
1978;33:145-148.
31. Mondelli M, Rossi S, Monti E, et al. Prospective study of positive factors for
improvement of carpal tunnel syndrome in pregnant women. Muscle and Nerve.
2007;36:778-783.
32. Stolp-Smith K, Pascoe MK, Ogburn P, J. Carpal tunnel syndrome in pregnancy:
frequency, severity, and prognosis. Arch Phys Med Rehabil. 1998;79:1285-1287.
33. Tucker AT, White PD, Kosek E, et al. Comparison of vibration perception thresholds
in individuals with diffuse upper limb pain and carpal tunnel syndrome. Pain.
2007;127:263-269.
34. Leite J, Jerosch-Herold C, Song F. A systematic review of the psychometric
properties of the Boston Carpal Tunnel Questionnaire. BMC musculoskeletal disorders.
2006;7:78.
35. Katz JN, Gelberman RH, Wright EA, Lew RA, Liang MH. Responsiveness of selfreported and objective measures of disease severity in carpal tunnel syndrome. Med Care.
1994;32:1127-1133.

49
36. Chatterjee JS, Price PE. Comparative responsiveness of the Michigan Hand
Outcomes Questionnaire and the Carpal Tunnel Questionnaire after carpal tunnel release.
J Hand Surg Am. 2009;34:273-280.
37. Greenslade JR, Mehta RL, Belward P, Warwick DJ. Dash and boston questionnaire
assessment of carpal tunnel syndrome outcome: What is the responsiveness of an
outcome questionnaire? J Hand Surg. 2004;29 B:159-164.
38. McConnell SG, Beaton DE, Bombardier C. The DASH Outcome Measure User's
Manual First ed. Toronto, Ontario: Institute for Work & Health; 1999.
39. Kotsis SV, Lau FH, Chung KC. Responsiveness of the Michigan Hand Outcomes
Questionnaire and physical measurements in outcome studies of distal radius fracture
treatment. J Hand Surg Am. 2007;32:84-90.
40. Beaton DE, Katz JN, Fossel AH, Wright JG, Tarasuk V, Bombardier C. Measuring
the whole or the parts? Validity, reliability, and responsiveness of the Disabilities of the
Arm, Shoulder and Hand outcome measure in different regions of the upper extremity. J
Hand Ther. 2001;14:128-146.
41. MacDermid JC, Mulè M. Concurrent validity of the NK hand dexterity test.
Physiotherapy Research International. 2001;6:83-93.
42. Turgeon TR, MacDermid JC, Roth JH. Reliability of the NK dexterity board. J Hand
Ther. 1999;12:7-15.

50
43. Portney LG, Watkins MP, eds. Foundations of Clinical Research Applications to
Practice Second Edition ed. Upper Saddle River, New Jersey: Prentice Hall Health;
2000.
44. Stern LD. A Visual Approach to SPSS for Windows. 2nd ed. Pearson; 2010.
45. Gardner RC. Psychological Statistics using SPSS for Windows. Prentice Hall Upper
Saddle River, NJ; 2001.
46. Finch E, Dina. Brooks, Stratford PW. Physical rehabilitation outcome measures. .
2002.
47. Worster A, Fan J, Upadhye S. Understanding receiver operating characteristic (ROC)
curves. CJEM. 2006;8:19-20.
48. Liang H-, Wang Y-, Pan S-, Wang T-, Huang T-. Asymptomatic Median
Mononeuropathy Among Men With Chronic Paraplegia. Arch Phys Med Rehabil.
2007;88:1193-1197.
49. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR. Methods to explain the
clinical significance of health status measures. Mayo Foundation; 2002;77:371-383.
50. Yost KJ, Eton DT. Combining distribution-and anchor-based approaches to determine
minimally important differences. Eval Health Prof. 2005;28:172-191.
51. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health
status. Med Care. 1989:178-189.

51
52. Liang MH, Larson MG, Cullen KE, Schwartz JA. Comparative measurement
efficiency and sensitivity of five health status instruments for arthritis research. Arthritis
& Rheumatism. 2005;28:542-547.
53. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum;
1988.
54. Cohen J. Statistical power analysis for the behavioral sciences. . 1977.
55. Shi Q, MacDermid JC. Is surgical intervention more effective than non-surgical
treatment for carpal tunnel syndrome? a systematic review. Journal of orthopaedic
surgery and research. 2011;6:1-9.
56. Chung KC. The Minimal Clinically Important Difference of the Carpal Tunnel
Syndrome Symptom Severity Scale. J Hand Surg. 2006;31:739-740.
57. Kamper SJ, Maher CG, Mackay G. Global rating of change scales: a review of
strengths and weaknesses and considerations for design. The Journal of manual &
manipulative therapy. 2009;17:163-170.
58. Herrmann D. Reporting Current, Past, and Changed Health Status: What We Know
about Distortion. Med Care. 1995;33:AS89-AS94.
59. Tassler P, Dellon A. Correlation of measurements of pressure perception using the
pressure-specified sensory device with electrodiagnostic testing. Journal of Occupational
and Environmental Medicine. 1995;37:862.

52
60. Dogan SK, Ay S, Evcik D, Baser O. Adaptation of Turkish version of the
questionnaire Quick Disability of the Arm, Shoulder, and Hand (Quick DASH) in
patients with carpal tunnel syndrome. Clin Rheumatol. 2011;30:185-191.
61. Gehrmann S, Tang J, Kaufmann RA, Goitz RJ, Windolf J, Li Z-. Variability of
Precision Pinch Movements Caused by Carpal Tunnel Syndrome. J Hand Surg.
2008;33:1069-1075.
62. Van Brakel W, Khawas I, Gurung KS, Kets C, Van Leerdam M, Drever W. Intra-and
inter-tester reliability of sensibility testing in leprosy. International journal of leprosy and
other mycobacterial diseases: official organ of the International Leprosy Association.
1996;64:287.

53

Chapter 3

3

A Pilot Study to Determine the Effect of Cell Phone Texting on Patients with
Carpal Tunnel Syndrome (CTS)
Cheung DKM, MacDermid JC, Grewal R
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3.1

Introduction

Text messaging is a common method of communication. Between the years 2001 to
2011, there was a substantial increase in the number of cell phone subscribers and text
messages sent in the United States of America.

1

A recent study examined the nature of

cell phone usage over 2001-2011 and found at that in 2001, there were128.4million cell
phone subscribers and 252.8 million text messages sent per month in U.S.

1

Ten years

later, the number of cell phone subscribers has increased to 331.6 million and
193.1billion text messages were sent per month. In 2011, an average of 20 text messages
were sent per day per user; although there is wide variability in usage. 1
Case studies have reported that many adolescents and adults have suffered from injuries
sustained from prolonged thumb texting activity.

2, 3

Case studies and observational

studies have indicated injuries such as joint arthritis, tendonitis in the thumb,
tenosynovitis suggesting a link to excessive texting.

3

4

and

A biomechanical study has

indicated that people suffering from pain and numbness in the upper extremity (neck,
arm, or hand) had lower muscle activity in the trapezius, but higher muscle activity in the
thumb during a texting activity compared to non-symptomatic individuals.

5

This

suggests an etiologic basis for hand pathology with excessive texting. Other studies have
also indicated physiological changes from texting in healthy individuals, such as
increased trunk stability, and changes in breathing patterns. 6 However, it is not clear how
patient populations such as people with Carpal Tunnel Syndrome (CTS) are affected by
texting. It might be assumed that pre-existing pathology increases the potential for
adverse effects of texting. It is also unclear how the performance of patients with CTS
might be impaired or different from individuals without CTS.
Carpal Tunnel Syndrome (CTS) is a common neuropathy associated with vascular,
sensory, and motor impairments in the hand and the wrist. 7, 8 Classical symptoms for the
diagnosis of CTS include: altered sensation, numbness, tingling, and occasionally pain in
the hand.

7, 8

Studies suggest that these symptoms are aggravated from the increase in
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carpal tunnel pressure within the carpal tunnel structure,
anatomical structures

12

against the median nerve.

9-11

which compresses

Carpal tunnel pressure varies

depending on the posture of the wrist (flexion, extension, radial deviation, or ulnar
deviation), forearm posture (pronated, semi-pronated, or supinated), and the finger
posture (closed, pinch, straight, or relaxed). 7 9 Carpal tunnel pressures are the highest at
extreme ranges of motion for the wrist depending on the postures of the fingers, and
forearm.

13

Cell phone texting is commonly performed with the thumbs and may be

characterized by both wrists in ulnar deviation and the fingers are in a closed or pinching
position around the cell phone device. The thumbs perform repetitive motion of pressing
against keys, while the other digits are flexed and grip the device.
Understanding the impact of texting on a patient population with CTS would inform our
understanding about the nature of patients’ symptoms with activity; and help clinicians
make recommendations about the use of cell phones. Therefore the purposes of this study
were:
1. To determine the feasibility of conducting a large cohort study examining longterm risks of texting in patients with CTS and normal age-matched controls
2. To establish the potential immediate effects that might be anticipated on
superficial blood flow, sensory threshold and symptoms in response to texting
3. To determine difference in texting performance between patients with CTS and
normal age-matched controls

3.2

Hypotheses:

1. We anticipate that feasibility will be demonstrated:
a. If outcome measure variability suggests that a long–term cohort study
could be conducted with less than 300 subjects in total
b. If exclusion rates did not exceed 60%
c. If participation rates exceeded 20%

56
d. The rate of withdrawal does not exceed 20%
2. Patients with CTS will have significantly lower superficial blood flow, higher
touch threshold, and worse symptoms than healthy controls. Significant changes
will occur to measurement outcomes immediately after texting for patients only.
3. Patients with CTS will text significantly fewer characters, shorter duration, and
slower average texting speed compared to healthy controls.

3.3

Materials and Methods:

Patients with known CTS were recruited from a tertiary health care setting was confirmed
by one of three hand surgeons using clinical tests and results from electrodiagnostic
studies. Patients were informed about the study either through the treating surgeon or
through administrative staff. Patients were excluded from the study if they had one of the
following exclusion criteria:


Received previous surgery for CTS



Insulin dependent Diabetes



Younger than 18 years old or older than 65 years old



Recent or current injury to the upper extremity, including neck – muscle, bone, or
nerve injury (within the past year)



Osteoarthritis



Heart Condition



Ongoing cancer



CTS with ongoing pregnancy



Vascular problems with the hands or arms (i.e. Raynaud’s Syndrome)
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Age and gender matched persons without CTS were also recruited as controls for the
study. The controls were recruited through posters advertisement in the hospital and
through word of mouth to hospital staff (physiotherapists, occupational therapists, and
administrative staff), and graduate students. When controls were recruited by word of
mouth, the primary investigator explained the study at staff meetings to inform and guide
staff to decide whether they would be interested and/or eligible for the study. Exclusion
criteria were explained to staff to advise them to whether they were eligible for the study
or not. Hard copies describing the study, contact information, and a sign-up sheet were
given to staff. Patients were matched with controls recruited for the study within an age
range of ± 5 years. Persons who were 65 years old were matched with a control between
ages 60 to 65 years old to stay within the age bracket of the study. Patients were matched
to age and gender matched controls to allow for matched comparisons and improve
statistical power. Recruitment of the controls was based on the same exclusion criteria as
patients with CTS to participate in the study. Only one visit was required for the study
for each participant. Each participant was asked not to consume any caffeine (i.e. tea or
coffee) 4 hours before the study. All participants who participated in the study
understood the letter of information and provided signed consent to participate in the
study.

3.4

Outcome Measures:

TIVI (Tissue Viability Imaging) 600 polarization spectroscopy camera (version 7.4
Wheelsbridge AB, Linköping, Sweden): TIVI software was used to quantify red blood
cell concentration on the palmar side of the hand using a digital camera (Canon Rebel
EOS model 450D, Japan) with a polarization lens. The camera was supported by a multijointed metal arm provided by Wheelsbridge and the arm was secured to a desk. The
camera was adjusted to point downwards towards the surface of the desk. A royal blue
coloured file folder was placed under the camera to fill the camera view. An outline was
drawn on the blue folder to standardize hand positioning for the left and right hand. Each
participant was required to place their hand in line with the outline with hand(s) in
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supinated position with the skin grooves for each interphalangeal joint of the fifth
phalange in line with specific markings on the hand outline. The participants were asked
to keep their palms in an open position with all fingers and their thumb in line with each
other. Each image was captured with the polarized lens set at the cross polarization
setting and the camera was positioned at a distance between 200mm to 300mm from the
participant’s hand. Image quality was set to medium normal. One photo was taken every
5 seconds and uploaded into the attached laptop computer. The camera has a light
penetration depth between 400 to 500 micrometers. 14
Once the images were captured, the TIVI images were processed using the TIVI
software. For each participant, one image at baseline and at each follow up point (0, 2, 5,
and 10 minute(s) after texting) were used for processing and analysis, for a total of 5
images per participant. If the participant had bilateral CTS, only one hand (left or right)
was processed and analyzed for this study. For patients with bilateral CTS, the hand with
more severe symptoms as defined by the SSS was used for processing and analyzed. If
only one side was affected with CTS, that hand would be used. The same sided hand was
processed for matched controls. Regions of Interest (ROI’s) were selected at the distal
pulps of each finger and the sum of the ROI’s represented total blood flow in the hand.
Curve tracker was used to produce a spread sheet categorizing the magnitudes of red
blood cell concentration by the selected ROI’s. Values for the TIVI are measured by
Arbitrary Units (A.U.). Data was exported from the TIVI software into Microsoft Excel
2007 spreadsheets via Curve Tracker and then imported into SPSS version 19.0 for
analysis. The TIVI has been validated for construct validity to measure superficial red
blood cell concentration with in vitro fluid models and computer simulations.

14, 15

The

models performed in vitro demonstrated that the TIVI software was able to accurately
calculate the oxygen saturation level of 91.5%, which is within the physiological range of
oxygen saturation within blood.
during blood occlusion testing,
inter-laboratory reliability.

17

14

15

The TIVI has been shown to be sensitive to change

and drug testing on skin. 16 The TIVI has demonstrated

When 4 TIVI units were tested in two different sites with

identical protocols, the average systematic drift was <1.02% for all 4 units under the
same protocol.

17

When the same protocol was repeated 2 months later, TIVI
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demonstrated test retest reliability.

17

The maximum percentage deviation ranged from

0.74% to 1.7%. 17
Pressure Specified Sensory Device (PSSD) (NK Biotechnical Corporation,
Minneapolis, MN, USA): This computerized tool measures touch threshold or the
amount of pressure required to elicit a response on the distal pulp of the thumb. The
PSSD was collected with the participant seated at the testing station and with the
participant resting his hand in a supinated position on a piece of foam and asked to close
his eyes. The tester would gently touch the pulp of the thumb at 5 different points with
the PSSD device and the participant would respond when they detected the stimuli by
pushing a trigger in the other hand. The highest and lowest values were discarded and
the average of three values was recorded as the measure of touch threshold. The PSSD
has been evaluated for reliability (r= 0.95) and inter-rater reliability in patients with
neuropathy for one point static testing (r= 0.93 - 1.00). 18
Numeric Rating Scale for Pain: This scale allowed patients to rate their measured pain
in the hand at a specific point in time. The numeric rating scale ranges from 0 to 10.
Participants were asked to first rate their pain between 0 (not experiencing the symptom
at all) to 10 (worst possible rating) verbally. The first author (DC) would mark down the
rating to the corresponding scale. For bilateral CTS cases, the hand chosen for analysis
was the side which had greater symptom severity based on the patient’s concern, and
from patient lists. For unilateral cases, the affected side was tested. For controls, the side
tested was matched to the patient’s same side. The numeric pain rating scale has been
validated for examining changes in pain qualities in CTS after treatment. 19
Numeric Rating Scale for Numbness: Numeric rating scales for measuring numbness
have been suggested to be valid for measuring the severity of Carpal Tunnel Syndrome.
20, 21

The numeric rating scale ranges from 0 to 10. Participants were asked to first rate

the amount of numbness they experienced in their hand between 0 (not experiencing the
symptom at all) to 10 (worst possible rating) verbally. The first author (DC) would mark
down the rating to the corresponding scale. For bilateral CTS cases, the hand chosen for
analysis was the side which had greater symptom severity based on the patient’s concern,
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and from patient lists. For unilateral cases, the affected side was tested. For controls, the
side tested was matched to the patient’s same side.

The numeric rating scale for

numbness is a component of the PQAS (Pain Quality Assessment Scale), and measures
sensibility impairment, similar to the Ten test. The PQAS is a 20 item scale which allows
the patient to rate various components of pain between 1 (none) to 10 (worst). The
numeric rating scale for numbness in the PQAS has been shown to be a responsive tool
for measuring change in numbness (ES = 1.27) after treatment for CTS with injection and
lidocaine patch, separately. 19 The Ten test is a sensory test where patients rate the extent
of sensory impairment between 1 (impaired) to 10 (normal or best sensibility). The test
retest reliability of the numeric rating scale for numbness has not been verified, but the
Ten test

22

has been verified to show inter-rater reliability (ICC = 0.91) for 49 patients

with peripheral nerve disorders.
Numeric Rating Scale for Fatigue: The purpose of the numeric rating of fatigue is to
rate perceived fatigue after an activity. The numeric rating scale ranges from 0 to 10.
Participants were asked to first rate the amount of fatigue they experienced in their hand
between 0 (not experiencing the symptom at all) to 10 (worst possible rating) verbally.
The first author (DC) would mark down the rating to the corresponding scale. For
bilateral CTS cases, the hand chosen for analysis was the side which had greater
symptom severity based on the patient’s concern, and from patient lists. For unilateral
cases, the affected side was tested. For controls, the side tested was matched to the
patient’s same side.

The numeric rating scales for fatigue and numbness have been used

in new patients with cancer receiving chemotherapy

23

for rating fatigue and numbness

affecting the whole body. We are uncertain if the numeric rating scale for fatigue is valid
and reliable for patients with CTS after performing an activity because this application
has not been tested, but numeric rating of pain and other symptoms have been
consistently high across numerous contexts.
Symptom Severity Scale (SSS): The SSS is a self-report questionnaire designed for
measuring symptoms experienced by patients with CTS.

24

The SSS is composed of 11

questions each rated 1 through 5 that measures symptoms experienced in a typical 24
hour period within the past 2 weeks. Respondents rate the severity of CTS-related
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symptoms and disability where a rating of 1 indicated that there was no symptom at all,
and 5 represented the worst symptom experienced. 24 Rating the scale was done for both
the left and right hand to determine which hand was worse. The mean score was
calculated for each hand and the hand with the higher score was used as the final score
for calculations in this study. The SSS has been assessed and found to be valid for face,
content, and construct validity in measuring clinically relevant change in patients with
CTS.

24

The SSS was used to determine which hand had more severe symptoms in

bilateral cases. The SSS has also been shown to be reliable 24, 25 and responsive. 26, 27
Texting Performance: For texting performance, we wanted to observe the number of
characters texted, duration texted (seconds), and the texting speed (characters/second).
The number of characters texted was counted for each participant. This value was the
sum of the number of characters and the number of spaces entered into the cell phone
during the visit for each participant. Each text message was sent to an email account and
then copied to a word processing software (Microsoft Office 2010). The number of
characters was counted using a count feature within word processing software to count all
characters and spaces in the text messages. The duration each participant was able to text
was timed with a digital timer in seconds. The timer counted down from 15 minutes.
The duration of texting recorded was when the time was up or if the patient requested to
stop texting early because of symptoms; whichever was first.

The texting speed was

calculated by dividing the number of characters and spaces entered into the cell phone it
by the duration in seconds which the participant was texting.

3.5

Procedure:

The letter of information was explained to each participant and consent was provided.
Then, each participant provided the following demographic information: age, gender,
duration of symptoms (for patients only), which hand was affected (for patients only),
hand dominance (left or right), whether the injury was involving Workplace Safety and
Insurance Board (WSIB), and familiarity with texting on a QWERTY phone (yes or no).
Then the SSS was completed. Data for the TIVI, the numeric rating scale for pain,
fatigue, and numbness, and the PSSD were collected at rest (in this order).
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Participants were then asked to perform a standardized texting task. Immediately after
texting, data for the TIVI, PSSD, and the Numeric Rating Scale for Pain, Fatigue, and
Numbness were collected. These outcome measures were measured again at 2 minutes, 5
minutes, and 10 minutes after texting.

3.6

Intervention:

During the texting activity, patients and controls were asked to text with a cell phone
while seated and to use only their thumbs to text in their response to questions from a
questionnaire. The same cell phone was used for all the participants and all participants
used the QWERTY key pad on the cell phone. The questionnaire was composed of 60
questions which allowed for open ended responses. The questionnaire asked patients
general questions regarding how participants learn about the study, or where did they
plan to go after the study. The questionnaire was designed for this study and is not a
standard part of patient care. Participants were asked to place a space between each word
they entered. After each question, participants were asked to place a period and then
proceed to the next question. This period was used by the authors to separate each
response in the questionnaire. Since the cell phone had a limit of 600 characters per text
message, once text message reached 600 characters, each text message was sent to the
first author’s email account. After each message was successfully sent, the participant
continued texting from the questionnaire. Each participant performed the texting activity
for a maximum time of 15 minutes. If the activity was too uncomfortable, the time of
pain free typing was recorded.

If participants completed answering the entire

questionnaire, the participants were asked to complete the questionnaire again until 15
minutes had elapsed from the start of the texting activity. The cell phone was set to
prevent word prediction to complete the replication of the script.

Cell Phone Model: The cell phone that was used for the study was a LG Rumour 2 (LG
Corp, Seoul, South Korea) which has a sliding QWERTY touch key pad for entering text
message. A QWERTY key pad is type of key pad interface where the top left letter row
read from left to right is Q-W-E-R-T-Y. Only the QWERTY key pad was used in this
study. A T9 key pad which was also available on the phone (but not used for this study)
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is a key pad with 9 keys which has a predictive feature for letters or numeric characters.
The predictive word feature for the phone was turned off.
Table 3.1: Cell Phone Specification
Company and Model

LG Rumour 2

Dimensions (height x width x depth)

11.2 x 5.3 x 1.8 cm in QWERTY
mode)

Weight

120g

Resolution

240 x 320 pixels

Keyboard Input Text

QWERTY or T9

Maximum character and space storage 600
per text message

3.7

Analysis:

Objective 1: Sample Size Calculation for Feasibility Study. Sample size for future
cohort studies was calculated based on the observed variability of the measures in this
study trial. The sample size was determined using a sample size calculator based on a 2
sided test to determine a significant difference between the patient and control group as
independent variables

28

from http://stat.ubc.ca/~rollin/stats/ssize/n2.html at a power of

80% with α = 0.05. The value for x1 was a pooled score of patient and control scores at
baseline, and x2 was the sum of x1 and 20% 29 of x1 for each outcome measure, to account
for clinically important change. The standard deviations for the calculator were derived
from each of the 6 outcome measure based on x1 (Table 2). The minimum sample size
required for a full study ranged between 16 to 120 patient participants per group
depending on the outcome measure (Table 4). The sample size for a full study would
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depend on which outcome measure(s) will be used.

Statistical significance was

considered if p<0.05.

Objective 2 and 3:
Healthy Controls.

Determining Differences within and between Patients and
Generalized Linear Model (GLM)

30

was used to determine if

patients have different measures of blood flow, sensory threshold, and symptoms
compared to controls at baseline (compare SSS, TIVI, PSSD, and NRS for pain, fatigue,
and numbness) at rest and at each follow-up point after texting.

Interactions were

examined for significance between group and time. Post hoc analyses were performed
using Bonferroni Correction for non significant interactions to determine between group
differences. Pair wise comparisons 30 were used to perform within-group comparisons to
compare between baseline scores to each of the follow-up scores.

An analysis of covariance (ANCOVA)

30

was performed to compare texting

performances between patients and controls for the number of characters texted, time
texted, and texting speed. Experience with texting was controlled as a covariant.
Data was checked for normal distribution for each follow up point. Differences were
considered significant with p<0.05.

3.8

Results:

Seventy one patients were screened for the study using patient lists for 8 months from
mid January to mid September 2012. The data were considered normally distributed
because sample sizes were equal in both groups.

3132

Data had minor violations of the

assumption of circularity and adjustments were made with the Greenhouse-Geisser
epsilon to the degrees of freedom to correct for this violation. 32, 33 No data were missing.
Demographic information of participants is presented in Table 1.

Objective 1: Feasibility of the Research Study. We had a 21% accrual rate for
acquiring patients from the potential pool of available subjects, as we successfully
recruited 15 out of 71 eligible patients. Thirty nine patients (55% of potential patient
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participants) were excluded because they did not meet the inclusion criteria (Table 1b)
(Figure 1). Twenty two potential patient participants were approached (31%). Six
patients refused to participate when approached (Table 1c). Ten patients were not
approached (Table 1d). Sixteen patients were recruited for the study, indicating a 73%
recruitment rate. One patient withdrew from the study, indicating a withdrawal rate of 6%
(Table 1c). Thus, fifteen patient participants completed the study. Fifteen healthy age
and gender matched controls were also recruited as controls. The 3 main exclusion
criteria for excluding patients was because of age (patients were over 65 years old), from
co-morbidities to upper extremity, or from diabetes (Table 1b) The main reason potential
patients refused to participate in the study because they were not interested in the study,
as they had other commitments after their appointments.
participants were not approached (Figure 1).

Ten potential patient

The most common reason for not

approaching potential patient participants were the first author (DC) or administrative
staff missed the opportunity to approach the study to patients (Table 1d). Surgeons found
most patients were willing to participate in the study, unless patients did not have time
before or after the study to participate because of personal commitments. The study took
a maximum of 40 minutes to complete for each participant. For a full study to be
completed, the sample size per group will range between 16 to 120 patients or between
32 to 240 participants in total depending on the outcome measure (Table 4). In regarding
recruitment, recruitment was slow in the spring and summer months between May to
August. Only one patient came in during that time period. During the spring and
summer months were when most patients refused to participate because they had other
time commitments after their medical appointment.
In terms of methodological concerns, equipment and protocol was straight forward to
follow and complete. Training took 2 weeks for the evaluator at the laboratory to become
familiarized with using the five measurement outcomes. The evaluator required the most
time learning how to operate the TIVI system properly, as it was a new addition to the
existing laboratory. Learning to capture photos and analyze the data took 10 working
days. Two experienced research assistants trained the evaluator to use the PSSD for two
30 minute sessions.
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Objective 2:

Impact of Texting on Touch Threshold, Superficial Red Blood Cell

Concentration, and Symptoms.

Prior to texting, patients demonstrated significantly

higher touch threshold (4.04g/mm2 versus 2.62 g/mm2) (p = 0.014) (Table 2 and Figure
3) and higher ratings on symptoms (all p<0.05)(See Table 2 and Figures 4,5, and 6).
Patients had on average 3 points higher for pain and fatigue, and 4 points higher for
numbness than controls. There were no significant differences in superficial red blood
cell concentration between groups at baseline; although patient scores were on average 15
A.U. higher, but was not statistically significant (736 A.U. versus 682 A.U.) (p = 0.29).
After texting, touch threshold increased significantly for patients, and touch threshold
values did not return to baseline levels at 10 minutes after texting (Table 2 and Figure 3).
There were gradual increases in symptoms of pain, and numbness after texting for the
patient group, but the increases were not significantly different from baseline. Fatigue
increased significantly only immediately after texting Table 2 and Figure 6).

All

outcome measures for the control group did not change significantly from texting.

3.8.1.1

Description of Outcome Measures at Baseline,
Immediately after Texting, 2 minutes, 5 minutes, and 10
minutes after Texting

Superficial Red Blood Cell Concentration. At baseline before texting, patients
had 8% more superficial red blood cell concentration compared to controls
(736.08 A.U. versus 682.20 A.U. for patients and controls respectively), but was
not significantly higher than baseline (p=0.29). After texting, patients had a
decrease of 0.3% from baseline following texting, and controls had a decrease of
2.2% from baseline superficial red blood concentration immediately following
texting. No significant changes were found over time (p=1.00).
Red blood cell concentration remained relatively constant throughout the study
(p=1.00), and patients had higher red blood cell concentration compared to
controls, but was not significantly higher (p = 1.00) (Figure 2). For patients, red
blood cell concentration decreased from 736.08 at baseline to 733.88 immediately

67
after texting (0.3% decrease from baseline). Patients had a decrease immediately
after texting from 733.88 A.U. to 704.49 A.U. at 2 minutes (4.3% decrease from
baseline), 751.45 A.U. at 5 minutes (2% increase from baseline), and 705.54 A.U.
at 10 minutes after texting (4% decrease from baseline). Controls had a decrease
immediately after texting from 682.2 A.U. to 667 A.U. (2% decrease from
baseline). The red blood cell concentration for controls decreased from baseline
at 682.20 A.U. to 667 A.U. at 2 minutes,(0.7% decrease from baseline), then
decreased to 675.16 A.U. at 5 minutes (1% decrease from baseline), and then
decreased to 644 A.U. at 10minutes after texting (5.6% of baseline).
Touch Threshold. Patients had 53% higher touch threshold values compared to
controls at baseline before texting (4.04g/mm2 versus 2.62g/mm2 for patients and
controls respectively). Patients’ touch threshold significantly increased by 66%
from baseline immediately after texting (4.04 to 6.71g/mm2) (p = 0.008), whereas
the touch threshold for controls increased by 14% (2.62g/mm2 to 3.00g/mm2)
(p=1.00).
After texting, touch threshold values for patients remained higher than baseline,
and did not return towards baseline at 2, 5, or 10 minutes after texting. After
texting, touch threshold for patients decreased from 6.71g/mm2 to 5.51g/mm2 at 2
minutes (136% of baseline value)(p=0.09), increased to 6.19 g/mm2 at 5 minutes
(153% of baseline value)(p=0.02), and decreased to 5.51g/mm2 at 10 minutes
after texting (136% of the baseline magnitude)(p=0.035)(Figure 2). The touch
threshold value at 5 minutes and 10 minutes after texting were significantly higher
than the baseline value, but not the touch threshold value at 2 minutes after
texting. After texting, the control group experienced a decrease in touch threshold
from 3.00g/mm2 to 2.27g/mm2 at 2 minutes (87% of baseline value), then
increased to 2.48 g/mm2 at 5 minutes (95% of baseline value), and then increased
to 2.45g/mm2 at 10 minutes after texting (94% of baseline value). No significant
differences were found between baseline and follow up values for the control
group (p = 1.00).
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Pain. At baseline before texting, patients had pain ratings 3 points higher than
controls (2.73 versus 0.07 points for patients and controls respectively) at baseline
(Table 2). Patients experienced significantly more pain than controls (p<0.05).
After texting, patients experienced an increase of 1 point more pain (2.73 and 3.87
points before and after texting respectively), although not significantly higher
than baseline (p=0.152), whereas the controls did not experience substantial
change in pain ratings after texting (0.07 to 0.13 points before and after texting
respectively) (p=1.00).
After texting, pain ratings decreased towards scores at baseline for patients and
pain scores were not significantly different from baseline (p=0.15 -1.00). Pain
ratings remained relatively unchanged for controls (p=1.00) (Table 2 and Figure
4). Differences on pain ratings were +0.07, -0.2, and +0.2 point between baseline
and follow up scores at 2 minutes, 5 minutes, and 10 minutes respectively after
texting for patients. The differences in pain ratings for controls between baseline
and follow up points at 2, 5, and 10 minutes after texting were 0, +0.13, and -0.07
point respectively. Pain scores after texting did not differ significantly from the
baseline pain score (p = 1.00).

Numbness.

Patients had numbness ratings which were on average 4 points

higher than controls at rest, which was significantly higher (p<0.05). Patients
experienced an increase of 0.6 point in numbness after texting, whereas controls
had increase of 0.21 point in numbness ratings. Neither group experienced a
significant change in numbness after texting (p=1.00).
After texting, rating score for numbness decreased towards baseline for the patient
group.

Differences on ratings for numbness were +0.27, -0.33, and 0 point

between baseline and follow up scores at 2 minutes, 5 minutes, and 10 minutes
respectively after texting for patients. The differences in ratings for numbness
between baseline and follow up points at 2, 5, and 10 minutes after texting were
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+0.07, +0.14, and 0 point respectively for controls, which were not significantly
different from the baseline value (p=1.00) (Table 2 and Figure 5).
Fatigue. Patients had fatigue ratings which was 3 points higher than controls at
baseline. Patients had fatigue ratings 2 points higher than controls (p<0.05).
Patients experienced a significant increase of 2 points in fatigue rating
immediately after texting (p=0.016), whereas controls had a 1 point increase in
fatigue immediately after texting, although the change was not significant from
baseline (p=0.33).
After fatigue increased from texting, fatigue ratings decreased towards scores at
baseline for patients and controls (Table 2 and Figure 6). Differences on ratings
for fatigue were +0.4, -0.06, and +0.14 point between baseline and follow up
scores at 2 minutes, 5 minutes, and 10 minutes respectively after texting for
patients. No significant differences were found between baseline and follow up
points for patients (p=1.00).

The differences in ratings for fatigue between

baseline and follow up points at 2, 5, and 10 minutes after texting were +0.6,
+0.33, and +0.13 point respectively.

No significant differences were found

between baseline and follow up points for controls (p=1.00).
Objective 3: Performance differences between Patients and Controls. When
experience was controlled for in texting performance, patients with CTS texted
fewer characters [F (1,27) = 19.81 (p<0.05), ƞ

2

= 0.42] (Table 3) and had a

slower texting speed than controls [F(1,27) = 22.63 (p<0.05), ƞ 2 = 0.46)] (Table
3). No difference was found in the duration of time patients and controls were
able to text (F(1,27) = 2.50 (p=0.13), ƞ

2

= 0.085) (Table 3). All 15 controls

performed 15 minutes of texting, but only 12 out of 15 patients completed the full
15 minutes.
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Table 3.1a 1 Sample Characteristics
Characteristics

Patients (mean ± SD)

Controls (mean ± SD) (median)

(median)
Age(years)

Men: Women
Symptom Duration

48 years old ± 11 years

46 years old ± 11 years

(50)

(49)

7:8

7:8

266 ± 425.75

Does not apply

(weeks) (±SD)
(112)
right: left hand ratio

10:5

10:5

Ratio of

10:5

10:5

3.04

1

participants familiar
with texting on
QWERTY keypad:
Not familiar with
texting on
QWERTY keypad
SSS

SD = Standard Deviation. SSS = Symptom Severity Scale
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Table 3.1b 1: Reasons for Lack of Eligibility Based on Exclusion Criteria
Exclusion Criteria

Description of

Number of

Percentage of Total

Exclusion Criteria

Patients

Potential Patient

Excluded from

Participants

Study
Diabetes

Diabetes can impair

7

9.9%

N/A

16

23%

Injury to Upper

Trigger finger, swelling,

10

14%

Extremity (Co-

elbow injury, and

morbidity)

osteoarthritis

Surgery has been

Surgery was performed

2

2.8%

done previously

previously by surgeons

2

2.8%

sensation in the hand.
Did not discriminate for
patients who are insulin
dependent. Patients
who are not dependent
on insulin may not have
impairments to
sensation.
Too old (>65 years
old)

at this site. Certain
health conditions may
be the cause of
patients to come in for
second surgery.
Heart Condition

Patients had abnormal
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heart beat which may
influence TIVI values.
CTS was not

Patients were

confirmed by

suggested to have CTS

surgeon on site

by their family

2

2.8%

39

55%*

physician
Total
*value has small degree of rounding error
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Table 3.1c 1: Reasons for Refusal to Participate
Reason for Not
Participating in Study

Number of Participants

Percentage of Total
Potential Patient
Participants

Not Interested

5

7.0%

Language barrier (i.e. did
not understand English)

1

1.4%

Withdrew from study (to
attend appointment with
surgeon)

1

1.4%

Total

7

10%*

*value has small degree of rounding error
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Table 3.1d 1 Reasons for Not Approaching Potential Participants
Reason for Not
Participating in Study

Number of Participants

Percentage of Total
Potential Patient
Participants

Timing (i.e. secretaries
felt it was too early in the
morning for patients and
commute to hospital)

2

2.8%

Missed opportunity to
5
recruit patient (i.e. illness)

7.0%

Patient Missed
Appointment with
Surgeon

3

4.2%

Total

10

14%*

*value has small degree of rounding error

Descriptive Data of Outcome Measures for Measuring Effects of Texting
Tool

Group

Baseline

Immediately after

2 min after Texting

5 min after

10 min after

Texting

Texting

6.19

5.51

(5.58)

(3.91)

Texting

PSSD

Patient

Control

TIVI

Patient

Mean (SD)

4.04

6.71

5.51 (3.51)

(3.36)

(5.94)

Median

3.00

4.70

5.20

5.20

4.70

Mean (SD)

2.62

3.00

2.27

2.48

2.45

(1.84)

(2.10)

(1.60)

(1.66)

(1.64)

Median

1.80

2.00

1.70

1.70

1.90

Mean (SD)

736.08 (154.43)

733.88

704.49 (129.79)

751.45

705.54

(133.00)

(104.69)

(149.90)

Control

Median

714.82

730.00

690.23

778.93

677.94

Mean (SD)

682.20 (185.54)

667.00

683.00 (180.00)

675.16 (182.48)

644.00

(16.20)
Median

664.04

662.50

(147.71)
648.33

649.56

646.64
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Tool

Group

Baseline

Immediately after

2 min after Texting

5 min after

10 min after

Texting

Texting

Texting

Pain

Patient

Control

Fatigue

Patient

Control

Mean (SD)

2.73 (2.01)

3.87

2.80

2.53

2.93

(2.77)

(2.83)

(3.00)

(2.88)

Median

3.00

3.00

2.00

1.00

2.00

Mean (SD)

0.07

0.13

0.07

0.20

0.00

(0.26)

(0.35)

(0.26)

(0.56)

Median

0.00

0.00

0.00

0.00

0.00

Mean (SD)

2.93

4.80

3.33

2.87

3.07

(2.31)

(2.98)

(2.91)

(2.85)

(2.60)

Median

3.00

5.00

2.00

2.00

2.00

Mean (SD)

0.07

1.27

0.67

0.40

0.20

(0.26)

(1.44)

(1.11)

(0.63)

(0.41)

0.00

1.00

0.00

0.00

0.00

Median
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Tool

Group

Baseline

Immediately after

2 min after Texting

5 min after

10 min after

Texting

Texting

Texting

Numb

Patient

Mean (SD)

4.00

4.60

4.27

3.67

4.00

(3.02)

(3.22)

(3.10)

(3.72)

(2.95)

Median

3.02

3.22

3.10

3.18

2.95

Mean

0.00

0.21

0.07

0.14

0.00

(0.77)

(0.27)

(0.36)

0.00

0.00

0.00

-ness

Control

Median

0.00

0.00

Table 3.2: Descriptive Data of Outcome Measures for Measuring Effects of Texting
SD = standard deviation. Min = minutes
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Characteristic of Texting

Patients

Controls

631 (246)

993 (209)**

809.87

900

0.76 (0.19)

1.10(0.23) **

80%

100%

Performance
Number of Characters
Texted (mean)(SD)
Duration of Texting
(seconds) (SD)
Average Texting Speed
(characters/second) (SD)
% Completed Texting Task

Table 3.3: Descriptive Data of Texting Performance
** = significantly higher
SD = Standard Deviation
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Figure 3.1: Flow Chart Detailing the Recruitment of Patient Participants
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Figure 3.2: Changes in Red Blood Cell Concentration in Patients over Time
TIVI = Tissue Viability Imaging
Min post = minutes post texting
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Figure 3.3: Changes in PSSD over Time for Patients and Controls
PSSD = Pressure Specified Sensory Device
Min post = minutes after texting
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**

Figure 3.4: Changes over time with Pain
Min post = minutes after texting
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Figure 3.5 Changes over time with Numbness
Min post = minutes after texting
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**

Figure 3.6: Change over Time with Fatigue
Min post = minutes after texting
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Measurement

Sample Size

Patients to be

Total Number of

outcome

Required per

Screened Based

Participants

group

on Accrual Rate
of 21%

PSSD

120

571

240

TIVI

23

110

46

Pain NRS

16

76

32

Fatigue NRS

36

171

72

Numbness NRS

36

171

72

Table 3.4: Comparison of Sample Sizes Required for a Full Study
PSSD = Pressure Specified Sensory Device, TIVI = Tissue Viability Imager, NRS =
Numeric Rating Scale

Pilot
Study Design
Exclusion Criteria

Test Retest study
 Received previous surgery for CTS
 Diabetes
 Younger than 18 years old or older
than 65 years old
 Recent or current injury to the upper
extremity, including neck – muscle,
bone, or nerve injury (within the past
year)
 Osteoarthritis
 Heart Condition
 Ongoing cancer
 CTS with ongoing pregnancy
 Vascular problems with the hands or
arms (i.e. Raynaud’s Syndrome)

Full Study
Test Retest study
 Received previous surgery for CTS
 Diabetes without altered sensation
from diabetes.
 Younger than 18 years old and under
65 years old
 Injury to the hand or wrist (i.e.
fracture, osteoarthiritis, amputation)
(within the past year)
 CTS with ongoing pregnancy
 Vascular problems with the hands or
arms (i.e. Raynaud’s Syndrome)

Rational for Changes to
Pilot Study
Appropriate for methodology
The exclusion criteria on recent injury
eliminated 14% potential candidates
from the study. It was the 2nd top
reason patients were excluded and too
conservative. Patient with recent minor
injuries should be allowed to participate.

Although some patients have diabetes,
they may not have impaired sensation.
Diabetics who do not require insulin
injection should not be excluded from
this study.

Aging is known to be factor to result in
peripheral nerve degeneration and
34, 35
touch threshold increases with age.
36-38

Sample Size

15 per group

Depends on outcome measure (Table 4)

http://stat.ubc.ca/~rollin/stats/ssiz
e/n2.html 28

Study Intervention

Texting on cell phone for 15 minutes from
questionnaire

Texting on cell phone for 15 minutes from
questionnaire.

Some participants were more familiar
with their own cell phone rather than the
one provided. Index finger could also
be used for texting.

Cell phone models and type should be
chosen carefully.
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Pilot
Setting

Measurement
Outcomes

Full Study
Research laboratory at tertiary health
care setting specializing in upper
extremity
 TIVI
 PSSD
 Numeric Rating Scale for Pain
 Numeric Rating Scale for Numbness
 Numeric Rating Scale for Fatigue

Rational for Changes to
Pilot Study
Research laboratory at tertiary health
care setting specializing in upper
extremity
 TIVI
 PSSD
 Numeric Rating Scale for Pain
 Numeric Rating Scale for Numbness
 Numeric Rating Scale for Fatigue

Pilot
Environment is suitable for recruiting
patients with CTS.

All tools were straight forward to
operate. Testing took maximum of 40
minutes to complete.

Table 3.5: Comparison of Exclusion Criteria, Sample Size, and Outcome Measures for Pilot and Full Study
TIVI = Tissue Viability Imaging, PSSD = Pressure Specified Sensory Device
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3.9

Discussion

In this pilot study, we examined the differences between and within a group of patients
with CTS and a group of age and gender matched controls after completing a texting task. This
study found that patients with CTS experienced more symptoms and had more impairment to
sensation compared to age and gender matched controls at all time points. In terms of texting
performance, patients also performed worse than controls.

Study Feasibility:
This pilot study can be expanded into a full study with some changes to the exclusion criteria.
Our primary focus for this study was to examine the feasibility of recruiting patients for this
study. We were able to determine a sample size that was under 300 subjects, have an exclusion
criteria rate less than 60%, participation rate greater than 20%, and have a withdrawal rate of less
than 20%. Recruitment of patient participants by surgeons seems to be the most optimal method,
as most patients were willing to participate. Our exclusion criteria for excluding any potential
patient with other recent hand injuries were too conservative at times. We felt that hand injuries
occur commonly and we were limiting our recruitment to patients with CTS and no other
injuries. For example, a patient who has a minor bruise or cut on the palms could be recruited.
In addition, diabetics who are not insulin dependent could be included in this study. Those with
diabetes were originally excluded from this study was because they were assumed to all suffer
from neuropathy and have altered sensation caused by diabetes. However, not all diabetics
suffer from peripheral neuropathy 39 and patients with diabetes without neuropathy could be
recruited for the study. These considerations may help increase the recruitment of patient
participants by changing the exclusion criteria to be more liberal. The age range was
appropriate, as we captured the age range of working adults and the ages when most patients
suffer from CTS. Aging has been associated to age related changes to sensory threshold 34, 35 3638

and it seemed appropriate to exclude adults over 65 years of age.
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Recruiting controls was not an issue for this pilot study, as many healthy hospital workers
were available for the study, and were willing to participate. Candidates who would qualify for
the control group would be considered anyone without CTS and any other injury to the upper
extremity. A total of 20 controls were recruited for the study, but only 15 controls were
analyzed. During the recruitment process of healthy controls, no records were made to document
how many hospital staff were asked to participate in the study. Controls were invited to be part
of the study by word of mouth and announcements made at the staff meetings at the hand therapy
and physiotherapy department of the tertiary center. Nineteen controls were recruited by word of
mouth and would probably be the best way to approach controls for a larger study. As for
posters posted in the hospital hallways, only one control was recruited. Overall, the best strategy
for recruiting controls seems to be by word of mouth and announcements.

As hypothesized, patients experienced more classical symptoms of CTS compared to
controls at baseline in this study. However, pain and numbness were not significantly different
after texting for the patient group, but scores did increase gradually during texting and decreased
after texting. Pain and numbness may have increased from wrist posture, combined with
constant gliding of the tendons in the carpal tunnel with repetitive forces, which could increase
the pressure exerted against the median nerve, and associated structures, aggravating symptoms.
Kier et al 9 did a biomechanical study examining the changes in carpal tunnel pressure from
changes in wrist posture (extension versus flexion and radial versus ulnar deviation) and with
finger posture (0, 45, or 90 degrees flexion). The study found that carpal tunnel pressure
increased the most with wrist extension with straight fingers. Radial and ulnar deviations also
increased carpal tunnel pressures. 9 This study suggested that the increased pressure could
aggravate symptoms in patients with CTS based on hand postures. 9In addition, since the texting
activity required force application on the distal pulp of the thumbs, it is possible the force could
also aggravate the symptoms during texting. Rempel et al 40 performed a biomechanical study,
and found that the application of a force at the tip of the digits increased carpal tunnel pressure.
In our study, posture and forces at the pulps of the thumbs were not measured, but could be
performed in future studies to track changes to these variables throughout texting. Most patients
in our study needed to shake their injured hand(s), or have the forearm point downwards with the
wrist in neutral position to minimize the numbness the patient participants were experiencing
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after texting. The neutral wrist posture and having the forearm pointing downwards may have
helped to alleviate symptoms by decreasing carpal tunnel pressure.

However, it is important to note that the gradual increase in pain and numbness lacked
potential power to conclude results on the effects of cell phone texting within groups. The small
sample size of 15 participants is not large enough to say this did not happen by chance. The
sample size calculation for each measurement outcome demonstrated that the sample size of 15
participants per group was too small (Table 4). A future study should be performed to determine
the sample size required for more conclusive results for within group comparisons.

Patients also demonstrated a significant increase in touch threshold after texting, and also
at 5 and 10 minutes after texting (Figure 2). It has been established in previous literature that
patients with CTS have higher touch threshold levels than healthy individuals.10, 11 Compression
of the median nerve may decrease the nerve conduction velocity and magnitude of signals from
the Merkel disks and Pacinian corpuscles, resulting in a higher touch threshold in the thumbs.
Thus, more pressure was required for patients to detect touch stimuli. In a study by Gelberman
et al, 41 the researchers tested the influence of different carpal tunnel pressures on touch
threshold, nerve conduction tests, and functional tests in 12 healthy individuals. The participants
had their carpal tunnel pressure increased with a catheter, and outcome measures were taken at
baseline and after carpal tunnel pressure were increased. 41 They found that as carpal tunnel
pressure increased, touch threshold values with the Semmes Weinstein monofilament also
increase. 41 There was an increase in self-reported parathesia with increased carpal tunnel
pressure. 41 This may suggest that texting on a cell phone increases carpal tunnel pressures for
patients with CTS, and results in increased touch threshold values. Even after the testing, PSSD
scores for patients did not return back to levels at baseline for patients. However, the PSSD may
have high measurement error, as the confidence intervals are fairly wide. The PSSD might be a
very sensitive tool for detecting abnormal sensation, as it has high sensitivity for detecting
diseases, such as neuropathies caused by diabetes, 42 and CTS.

43

Its sensitive nature might be

demonstrated in its ability to measure change after texting activity.
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Both controls and patients experienced fatigue after texting. A study that supports our
findings on fatigue examined the occurrence of muscle fatigue in the forearms of computer users
after prolonged typing. Lin et al 44 used electromyography to quantify forearm muscles in 30
female typists who typed for 2 hours continuously. They found that 74% of the measured
forearm muscles manifested fatigue, and that extensor digitorum communis presented more
fatigue than forearm flexor muscles.

44

The sensation of fatigue may have resulted from lactic

acid accumulation in the thenar and forearm muscles, as a result of contraction of muscles in the
hand during texting activity. Fatigue was present in the computer typing tasks requiring long
term dynamic contractions with forces less than 10% of maximum voluntary contractions. 44
Future research should be done to verify the mechanisms behind fatigue in low level hand
activity and in patient populations requiring cell phone texting as part of their daily activity.

Red blood cell concentration values from the TIVI remained relatively stable throughout the
study for both patients and controls. Patients had higher red blood cell concentration than the
controls throughout the study. This finding is similar to results a study by Gelberman et al, 41
where arterial and venous blood flow did not change by increases in carpal tunnel pressure
among healthy individuals. 41 Previous studies have found that patients with CTS have slower
blood flow compared to controls. 45, 46 The differences in findings in our study and previous
studies may be due to the penetration ability of the light used in quantifying blood flow between
different methods of examining blood flow. Other studies had used Laser Doppler Systems,
which examines deep into tissue and provide a more precise measurement of blood flow. The
TIVI software only measures red blood cell concentration on the superficial skin level, so deeper
blood flow was not measured. This study is one of the initial studies on measuring superficial
blood flow in patients with CTS. We suggest there should be more studies on this topic in the
future.

As expected, patients typed fewer characters and had slower texting speed. Patients may
have performed worse than controls because the texting activity may have aggravated their
symptoms, so the patients texted fewer characters and texted slower to reduce the symptoms. We
had 3 patients who stopped texting early before the 15 minute mark because the numbness was
too bothersome, and interfered with their ability to text. This was not the same found from
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Guftasson et al, where young adults were asked to text on a cell phone and had
electromyography and performance measurements (i.e. texting duration) taken. 5 In a subgroup
analysis of the group with hand/arm symptoms, they required less time to perform the texting
task compared to individuals without symptoms. 5 Despite this difference, our study had a
specific patient population which was clinically diagnosed and did not have comorbidities.

This study has a number of strengths and novel findings. It evaluated patients and controls
using self-reported measures which would accurately measure their symptoms which they feel
and how these symptoms changed over time. The tools used in this study are commonly used
within clinical and ergonomic settings and these tools would be highly accessible. This study
also compared patients with CTS to an age and gender matched control group. Our study had
patients between the age ranges of 29 to 65 years of age. Women between 35 to 44 years of age
have the highest rates of CTS claims from work, and for men between ages 35 to 54 years of age
in Canada. 47 Previous studies examining texting have primarily focused on younger adults in
university settings, 6, 48 49 , but did not report the ages of the participants. Additionally,
university students would not accurately represent the general working adult population between
35 to 65 years old. The texting activity was designed to simulate an environment outside of a
laboratory. The task allowed participants to choose a posture that was comfortable to them, to
accommodate for variability in hand, and trunk postures while in seated position. The
questionnaire used for the texting intervention also contained open ended questions, which
allowed for variability in responses according to the participants’ preferences.

Our study also had some potential weaknesses. We recruited a small sample size of patient
participants and controls. A larger sample of patient participants would be required to have
sufficient power in multivariate calculations, and decrease the probability of potential type II
error to allow for more conclusive results on between and within group differences. In addition,
we used only one model of cell phone for our study. The nature of the texting activity in this
study was restricted to texting with only the thumbs. Performance may vary depending on the
specific digits used for texting and on the model of cell phone used for texting. We recommend
future studies to use different models of cell phones.
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3.10

Conclusion and Implications:

This pilot study provides valuable information on how cell phone texting affect patients
with CTS. The study found that patients experienced more symptoms than controls after
texting. Patients with CTS also performed worse than age and gender controls in texting.
However, the results were under powered to make conclusive statements. This pilot
study also provides important information for future studies involving patients with CTS
and cell phone texting.
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4

Overview of this Thesis

The overall theme in this thesis was to explore the properties and applications for sensory
tools among patients with CTS. We wanted to explore how certain tools responded to
orthotic intervention and after common hand activities. The specific focus of this thesis
was to evaluate the psychometric properties (clinical important difference, construct
validity, and responsiveness) of sensory threshold tools after orthotic treatment in CTS
and to determine the effects of cell phone texting on blood flow and sensation in CTS.
The details of the findings of this thesis are:
In the first study, we tested two sensory tools (one for vibration threshold and one for
touch threshold). We determined the clinically important difference of the tool for
measuring touch threshold and the outcome measure for rating symptom severity. We
found that the tool for measuring vibration threshold demonstrated greater construct
validity to measures of hand function and was more responsive compared to touch
threshold.
In the second study, we determined the feasibility of conducting a large scale study in a
hospital setting and the adverse effects of cell phone texting in CTS in comparison with
healthy controls.

4.1

What is Already Known on This Topic

Sensory testing is a common method of verifying a diagnosis for neuropathy and for the
evaluation of neuropathy. The CID of the SSS has been determined for after surgery, 1
and steroid injection. 2 Sensory threshold tools have demonstrated substantial change
between preoperative measures and after surgery. 3 Sensory tools have also been found
to be reliable. 4-6 However, limited research has been done examining the construct
validity of sensory tools to functional measures, and the responsiveness of sensory tools.
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Texting on a cell phone has been shown to increase muscle activity in the musculature of
the hand in patients with upper extremity injury. 7 However, limited research has
examined the short term and long term effect of cell phone texting in patients with CTS.

4.2

What This Thesis Adds to Our Knowledge Base

The first study found the CID to discriminate patients who responded to orthotic
intervention for the PSSD and the SSS. The CID for the PSSD and the SSS were
0.15g/mm2 and 0.50 respectively. The Vibrometer is a better overall representation of
functional measures for the hand and is more responsive after orthotic intervention.
The second study determined that the recruitment of patient subjects was feasible to
expand into a larger study to compare the effects of cell phone texting in patients with
CTS with age-gender matched controls. Our study had a recruitment rate of 73%. In
order to complete a full study, we would need to have 182 participants (or 92 participants
per group) to complete a full study [based on an 80% power (α= 0.05, β= 0.20), and in
order to detect a 20% difference between-groups.]

4.3

Implications

Sensory evaluation is a determining component in a peripheral nerve entrapment,
especially in CTS. This thesis has provided evidence based research for two sensory
tools during the rehabilitation process to guide clinical decisions on interpreting sensory
measures. In addition, this thesis provides preliminary findings on the impact of specific
activities on patient symptoms during the recovery period. This thesis helps provide
insight for clinicians to answer the question, “How can I tell if the sensory ability and
symptoms in my patients are improving or worsening from a specific intervention or
activity?”
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4.4

Limitations

This thesis did have some limitations on the whole. We were unable to establish a cut
point for the Vibrometer for discriminating patients after orthotic intervention. All
subjects who were tested with the Vibrometer had achieved an important improvement on
the SSS. We also had inconclusive findings on the impact of texting on superficial blood
cell concentration, sensory threshold and symptoms because of small sample size of n=15
in pilot study. We were unable to make conclusive statements about the impact of
texting, since it was under powered.

4.5

Future Research Directions and Recommendations



Recommendations for future psychometric studies:



Future studies should focus on examining the clinically important change on
commonly used tools in clinics.



Clinical tools should have their psychometric properties validated to provide
important information for clinicians, including reliability, validity, and the ability
of a tool to measure change.

8

The property of construct validity, responsiveness,

and clinically important change help to inform a clinicians’ decision when
treating patients with CTS.


Future studies should also examine the decision making process of how clinicians
use findings from sensory tools to inform their practice for treating CTS.

4.6


Recommendations and Future Research Directions for Pilot Studies:

A full study should be completed with 182 participants to evaluate the long term
effects of texting in patients with CTS and in healthy controls.



Exclusion criteria for recruiting participants should be more specific to clearly
identify eligible patients for the future full study.
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Different cell phone models should be tested to capture variability in texting
performances
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Appendix A 2 – Screen Tool for Chapter 3
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Screening Tool for CTS Study
Name: _____________________________
Date: _______________________________
This form will be completed by the potential participant to screen participants for the
study by verbal response to each question the investigator will read to him or her. The
investigator will fill in the form by putting an “x” in the boxes indicating Yes or No. If
the participant is uncertain, he or she will be asked to answer to the best of their ability.
Question
1. Are you confirmed by a health provider from St. Joseph’s hospital to have
Carpal Tunnel Syndrome?
2. Are you between the ages of 18-65 years old
3. Have you received any treatment offered by any hospital for the symptoms
for carpal tunnel syndrome?
4. Have you had a recent injury to your neck, shoulder, elbow, wrist, or hand
within the past year – muscle, bone, nerve injury, osteoarthritis (as of
January 2011)
5. Do you have a heart condition?
6. Are you a diabetic
7. Are you pregnant?
8. Do you have cancer or a tumour?
9.

Do you have any vascular problems in your hands or arms?

*If YES to 1 and NO to 3-9, then put into as PATIENT
*If No to 1, 3-9, then put into as CONTROL
*If yes to one of questions 3-9 regardless, then exclude from study

Yes

No
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If eligible as patient:
Thank you for your time. You are eligible for this study.

If not eligible as patient:
Thank you for your time. You are not eligible for this study. Is it okay though to
keep your name on our database so that we can contact you for other studies?

If eligible as control:
Thank you for your time. You are eligible for this study.

If not eligible as control:
Thank you for your time. You are not eligible for this study. Is it okay though to
keep your name on our database so that we can contact you for other studies?
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Appendix A 3 – Numeric Rating Scale for Pain, Fatigue, and Numbness
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Subject Code: _______________
Stage:______________

Numeric Rating Scale for Pain, Fatigue, and Numbness in the
Hand
At this moment:
Please rate the pain in each hand from 0-10. 0 being no pain. 10
being the worst pain experienced. Circle the corresponding
number and label it with “R” for right hand or “L” for left hand.

(NONE)
10

0

1

2

3

4

5

6

7

8

9

(WORST)

Please rate the fatigue in your hand from 0-10. 0 being no fatigue
in your hand. 10 being “too fatigued to continue.” Circle the
corresponding number and label it with “R” for right hand or “L”
for left hand.
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(NONE)
10

0

1

2

3

4

5

6

7

8

9

(WORST)

Please rate the Numbness or Tingling experienced in your hand
from 0-10. 0 being no numbness or tingling. 10 being unable to
feel anything. Circle the corresponding number and label it with
“R” for right hand or “L” for left hand.

(NONE)
10

0

1

(WORST)

2

3

4

5

6

7

8

9
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Appendix A 4 – Script
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Standardized Script (Dec 27, 2011).
Please respond to each of the questions with the cell
phone by texting in your response using only your
thumbs. After each response is entered, please enter
a period and a space before entering in the next
response.
This script will have repeated questions – just
continue answering them. If you make an error,
please correct the mistake with the delete button as in
the practice session.
Once time is up, please send the entire text to
derek.kmcheung@gmail.com .
1. How did you hear about this study?
2. Where do you plan to go after this study?
3. Where is your favourite place for vacation?
4. How many times have you been there?
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5. What would you recommend others to see if they went
to visit?

6. When is the next time you would like to visit that
place?

7. If you were given a billion dollars, what would you do
with it?
8. If you could give a billion dollars to anyone, who
would that be?
9. What is your favourite hobby?
10.

Would you do it for a living?

11.
If yes, why would you do it for a living? If no,
why not?
12.

What does TTYL mean?

13.

What does LOL mean?
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14.

What does TGIF mean?

15.

What does FYI mean?

16.

What does XOXO mean?

17.

What does BRB mean?

18.

Do you find this winter very cold?

19.

Are you a tea or coffee drinker?

20.

Have you had tea or coffee today?

21.

How did you hear about this study?

22.

Where do you plan to go after this study?

23.

Where is your favourite place for vacation?

24.

How many times have you been there?
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25.
What would you recommend others to see if they
went to visit?

26.
When is the next time you would like to visit that
place?

27.
If you were given a billion dollars, what would
you do with it?
28.
If you could give a billion dollars to anyone, who
would that be?
29.

What is your favourite hobby?

30.

Would you do it for a living?

31.
If yes, why would you do it for a living? If no,
why not?
32.

What does TTYL mean?

33.

What does LOL mean?
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34.

What does TGIF mean?

35.

What does FYI mean?

36.

What does XOXO mean?

37.

What does BRB mean?

38.

Do you find this winter very cold?

39.

Are you a tea or coffee drinker?

40.

Have you had tea or coffee today?

41.

How did you hear about this study?

42.

Where do you plan to go after this study?

43.

Where is your favourite place for vacation?

44.

How many times have you been there?
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45.
What would you recommend others to see if they
went to visit?

46.
When is the next time you would like to visit that
place?

47.
If you were given a billion dollars, what would
you do with it?
48.
If you could give a billion dollars to anyone, who
would that be?
49.

What is your favourite hobby?

50.

Would you do it for a living?

51.
If yes, why would you do it for a living? If no,
why not?
52.

What does TTYL mean?

53.

What does LOL mean?
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54.

What does TGIF mean?

55.

What does FYI mean?

56.

What does XOXO mean?

57.

What does BRB mean?

58.

Do you find this winter very cold?

59.

Are you a tea or coffee drinker?

60.

Have you had tea or coffee today?
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Appendix A 5 - Symptom Severity Scale
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Appendix A 6: DASH questionnaire
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